{"duration": "1y", "tickers": [{"address1": "777 Hidden Ridge", "city": "Irving", "state": "TX", "zip": "75038", "country": "United States", "phone": "972 444 9001", "website": "https://www.pxd.com", "industry": "Oil & Gas E&P", "industryKey": "oil-gas-e&p", "industryDisp": "Oil & Gas E&P", "sector": "Energy", "sectorKey": "energy", "sectorDisp": "Energy", "longBusinessSummary": "Pioneer Natural Resources Company operates as an independent oil and gas exploration and production company in the United States. The company explores for, develops, and produces oil, natural gas liquids (NGLs), and gas. It has operations in the Midland Basin in West Texas. Pioneer Natural Resources Company was founded in 1997 and is headquartered in Irving, Texas.", "fullTimeEmployees": 2076, "companyOfficers": [{"maxAge": 1, "name": "Mr. Scott Douglas Sheffield", "age": 69, "title": "CEO & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 4182833, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard P. Dealy", "age": 56, "title": "Pres, COO & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 1834803, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neal H. Shah", "age": 51, "title": "Exec. VP & CFO", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 1300259, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark S. Berg", "age": 63, "title": "Exec. VP of Corp. Operations", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 1224594, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jerome D. Hall Jr.", "age": 56, "title": "Exec. VP of Operations", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 1226259, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher L. Washburn", "age": 38, "title": "VP & Chief Accounting Officer", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bonnie S. Black", "age": 50, "title": "Sr. VP of Technology & Operations Support", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Larry N. Paulsen", "title": "Sr. VP of Admin. and Risk Management", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark H. Kleinman", "age": 60, "title": "Exec. VP & Gen. Counsel", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tyson L. Taylor", "age": 43, "title": "Sr. VP of HR & Communications", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 2, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 237.41, "open": 241.18, "dayLow": 237.45, "dayHigh": 241.2, "regularMarketPreviousClose": 237.41, "regularMarketOpen": 241.18, "regularMarketDayLow": 237.45, "regularMarketDayHigh": 241.2, "dividendRate": 16.47, "dividendYield": 0.0694, "exDividendDate": 1693872000, "payoutRatio": 0.986, "fiveYearAvgDividendYield": 3.53, "beta": 1.418942, "trailingPE": 10.157246, "forwardPE": 9.799098, "volume": 6057466, "regularMarketVolume": 6057466, "averageVolume": 1945450, "averageVolume10days": 3325590, "averageDailyVolume10Day": 3325590, "bid": 238.03, "ask": 238.3, "bidSize": 800, "askSize": 3100, "marketCap": 55720697856, "fiftyTwoWeekLow": 177.27, "fiftyTwoWeekHigh": 274.7, "priceToSalesTrailing12Months": 2.7331483, "fiftyDayAverage": 233.1822, "twoHundredDayAverage": 218.3314, "trailingAnnualDividendRate": 23.2, "trailingAnnualDividendYield": 0.09772124, "currency": "USD", "enterpriseValue": 60831039488, "profitMargins": 0.28395, "floatShares": 231509165, "sharesOutstanding": 233140992, "sharesShort": 3099149, "sharesShortPriorMonth": 3269881, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.013300001, "heldPercentInsiders": 0.00693, "heldPercentInstitutions": 0.86530995, "shortRatio": 1.68, "shortPercentOfFloat": 0.0134000005, "impliedSharesOutstanding": 233140992, "bookValue": 94.364, "priceToBook": 2.5327456, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": -0.535, "netIncomeToCommon": 5779999744, "trailingEps": 23.53, "forwardEps": 24.39, "pegRatio": -2.83, "enterpriseToRevenue": 2.984, "enterpriseToEbitda": 6.016, "52WeekChange": -0.03839767, "SandP52WeekChange": 0.2183963, "lastDividendValue": 1.84, "lastDividendDate": 1693872000, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "PXD", "underlyingSymbol": "PXD", "shortName": "Pioneer Natural Resources Compa", "longName": "Pioneer Natural Resources Company", "firstTradeDateEpochUtc": 871047000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "45d9eec3-b269-3316-bcbd-b145de6455e5", "messageBoardId": "finmb_295224", "gmtOffSetMilliseconds": -14400000, "currentPrice": 239.0, "targetHighPrice": 332.0, "targetLowPrice": 225.0, "targetMeanPrice": 263.0, "targetMedianPrice": 265.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 228000000, "totalCashPerShare": 0.978, "ebitda": 10110999552, "totalDebt": 5709000192, "quickRatio": 0.544, "currentRatio": 0.732, "totalRevenue": 20387000320, "debtToEquity": 25.95, "revenuePerShare": 86.386, "returnOnAssets": 0.12776, "returnOnEquity": 0.25285, "grossProfits": 13262000000, "freeCashflow": 3023000064, "operatingCashflow": 9575999488, "earningsGrowth": -0.512, "revenueGrowth": -0.349, "grossMargins": 0.52612, "ebitdaMargins": 0.49595, "operatingMargins": 0.36494, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "968 Albany Shaker Road", "city": "Latham", "state": "NY", "zip": "12110", "country": "United States", "phone": "518 782 7700", "website": "https://www.plugpower.com", "industry": "Electrical Equipment & Parts", "industryKey": "electrical-equipment-parts", "industryDisp": "Electrical Equipment & Parts", "sector": "Industrials", "sectorKey": "industrials", "sectorDisp": "Industrials", "longBusinessSummary": "Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.", "fullTimeEmployees": 3353, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew J. Marsh", "age": 66, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": 766555, "exercisedValue": 0, "unexercisedValue": 6044510}, {"maxAge": 1, "name": "Mr. Paul B. Middleton CPA", "age": 55, "title": "Executive VP & CFO", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 416555, "exercisedValue": 0, "unexercisedValue": 2351497}, {"maxAge": 1, "name": "Mr. Gerard L. Conway Jr.", "age": 57, "title": "Executive VP, General Counsel & Corporate Secretary", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 416555, "exercisedValue": 0, "unexercisedValue": 2020010}, {"maxAge": 1, "name": "Mr. Keith C. Schmid", "age": 59, "title": "Executive Vice President of Special Projects", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 416555, "exercisedValue": 0, "unexercisedValue": 3353757}, {"maxAge": 1, "name": "Mr. Jose Luis Crespo", "age": 52, "title": "Executive VP & GM of Material Handling", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 416555, "exercisedValue": 0, "unexercisedValue": 2020021}, {"maxAge": 1, "name": "Mr. Sanjay K.  Shrestha", "age": 48, "title": "Executive VP, GM of Energy Solutions & Chief Strategy Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 416555, "exercisedValue": 0, "unexercisedValue": 1006000}, {"maxAge": 1, "name": "Mr. Martin D. Hull", "age": 54, "title": "Chief Accounting Officer & Corporate Controller", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tim  Cortes", "title": "Chief Technology Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preeti  Pande Ph.D.", "title": "Chief Marketing Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tammy  Kimble", "title": "Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.16, "open": 7.8, "dayLow": 7.43, "dayHigh": 7.89, "regularMarketPreviousClose": 7.16, "regularMarketOpen": 7.8, "regularMarketDayLow": 7.43, "regularMarketDayHigh": 7.89, "dividendYield": 0.0456, "payoutRatio": 0.0, "beta": 1.934, "forwardPE": -13.833332, "volume": 25882915, "regularMarketVolume": 25882915, "averageVolume": 20716356, "averageVolume10days": 22841440, "averageDailyVolume10Day": 22841440, "bid": 7.58, "ask": 7.59, "bidSize": 3200, "askSize": 3100, "marketCap": 4496730624, "fiftyTwoWeekLow": 6.17, "fiftyTwoWeekHigh": 19.84, "priceToSalesTrailing12Months": 5.110862, "fiftyDayAverage": 8.5156, "twoHundredDayAverage": 10.92845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 4195821568, "profitMargins": -0.95152, "floatShares": 540986466, "sharesOutstanding": 601971968, "sharesShort": 127829032, "sharesShortPriorMonth": 120694753, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.2124, "heldPercentInsiders": 0.100159995, "heldPercentInstitutions": 0.56379, "shortRatio": 8.35, "shortPercentOfFloat": 0.214, "impliedSharesOutstanding": 601971968, "bookValue": 6.213, "priceToBook": 1.2023177, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -837182016, "trailingEps": -1.43, "forwardEps": -0.54, "pegRatio": 0.14, "lastSplitFactor": "1:10", "lastSplitDate": 1305849600, "enterpriseToRevenue": 4.769, "enterpriseToEbitda": -5.855, "52WeekChange": -0.6217644, "SandP52WeekChange": 0.2183963, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PLUG", "underlyingSymbol": "PLUG", "shortName": "Plug Power, Inc.", "longName": "Plug Power Inc.", "firstTradeDateEpochUtc": 941203800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c18d6117-2576-3244-a925-ea2b7aa66a49", "messageBoardId": "finmb_405483", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.47, "targetHighPrice": 78.0, "targetLowPrice": 7.5, "targetMeanPrice": 17.38, "targetMedianPrice": 14.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 29, "totalCash": 1084822016, "totalCashPerShare": 1.802, "ebitda": -716643968, "totalDebt": 970521984, "quickRatio": 1.694, "currentRatio": 3.162, "totalRevenue": 879838016, "debtToEquity": 25.956, "revenuePerShare": 1.498, "returnOnAssets": -0.085889995, "returnOnEquity": -0.20728001, "grossProfits": -167555000, "freeCashflow": -1298814592, "operatingCashflow": -1048521024, "revenueGrowth": 0.72, "grossMargins": -0.26843, "ebitdaMargins": -0.81452006, "operatingMargins": -0.80155, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "5959 Las Colinas Boulevard", "city": "Irving", "state": "TX", "zip": "75039-2298", "country": "United States", "phone": "972 940 6000", "website": "https://corporate.exxonmobil.com", "industry": "Oil & Gas Integrated", "industryKey": "oil-gas-integrated", "industryDisp": "Oil & Gas Integrated", "sector": "Energy", "sectorKey": "energy", "sectorDisp": "Energy", "longBusinessSummary": "Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, and catalysts, as well as licensing services. The Chemical Products segment manufactures and markets petrochemicals including olefins, polyolefins, and intermediates. The Specialty Products segment offers performance products, including lubricants, basestocks, waxes, synthetics, elastomers, and resins. The company is involved in the manufacturing, trade, transport, and sale of crude oil, natural gas, petroleum products, petrochemicals, and other specialty products; and pursuit lower-emission business opportunities including carbon capture and storage, hydrogen, and lower-emission fuels. Exxon Mobil Corporation was founded in 1870 and is headquartered in Irving, Texas.", "fullTimeEmployees": 62000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Darren W. Woods", "age": 57, "title": "Chairman of the Board, President & CEO", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 8463868, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathryn A. Mikells", "age": 56, "title": "Senior VP & CFO", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 5567842, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil A. Chapman", "age": 60, "title": "Senior Vice President", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 5248653, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack P. Williams Jr.", "age": 58, "title": "Senior Vice President", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 5400331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen T. McKee", "age": 54, "title": "VP & President of ExxonMobil Product Solutions Company", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 4605436, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard M. Fox", "age": 58, "title": "VP, Principal Accounting Officer & Controller", "yearBorn": 1964, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer K. Driscoll", "age": 56, "title": "Vice President of Investor Relations", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Craig S. Morford", "age": 63, "title": "VP, Secretary & General Counsel", "yearBorn": 1959, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Suzanne M. McCarron", "title": "Vice President of Public & Government Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tracey C. Gunnlaugsson", "title": "Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 1, "overallRisk": 7, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 110.45, "open": 106.96, "dayLow": 105.6612, "dayHigh": 107.17, "regularMarketPreviousClose": 110.45, "regularMarketOpen": 106.96, "regularMarketDayLow": 105.6612, "regularMarketDayHigh": 107.17, "dividendRate": 3.64, "dividendYield": 0.033, "exDividendDate": 1692057600, "payoutRatio": 0.2888, "fiveYearAvgDividendYield": 5.27, "beta": 1.044, "trailingPE": 8.5076, "forwardPE": 11.724917, "volume": 14629100, "regularMarketVolume": 14629100, "averageVolume": 16071909, "averageVolume10days": 18864740, "averageDailyVolume10Day": 18864740, "bid": 106.0, "ask": 106.06, "bidSize": 800, "askSize": 800, "marketCap": 423944355840, "fiftyTwoWeekLow": 97.23, "fiftyTwoWeekHigh": 120.7, "priceToSalesTrailing12Months": 1.1520947, "fiftyDayAverage": 112.0646, "twoHundredDayAverage": 109.829, "trailingAnnualDividendRate": 3.61, "trailingAnnualDividendYield": 0.03268447, "currency": "USD", "enterpriseValue": 462071627776, "profitMargins": 0.14055, "floatShares": 3997268062, "sharesOutstanding": 3986500096, "sharesShort": 44433891, "sharesShortPriorMonth": 38314422, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0111, "heldPercentInsiders": 0.00061, "heldPercentInstitutions": 0.60717, "shortRatio": 2.84, "shortPercentOfFloat": 0.0112, "impliedSharesOutstanding": 4003460096, "bookValue": 49.722, "priceToBook": 2.1387918, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": -0.559, "netIncomeToCommon": 51719999488, "trailingEps": 12.5, "forwardEps": 9.07, "pegRatio": -1.18, "lastSplitFactor": "2:1", "lastSplitDate": 995500800, "enterpriseToRevenue": 1.256, "enterpriseToEbitda": 5.839, "52WeekChange": 0.12211728, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.91, "lastDividendDate": 1692057600, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "XOM", "underlyingSymbol": "XOM", "shortName": "Exxon Mobil Corporation", "longName": "Exxon Mobil Corporation", "firstTradeDateEpochUtc": -252322200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "623c29c3-4307-34c2-840f-d89284dd4857", "messageBoardId": "finmb_406338", "gmtOffSetMilliseconds": -14400000, "currentPrice": 106.345, "targetHighPrice": 150.0, "targetLowPrice": 110.0, "targetMeanPrice": 125.73, "targetMedianPrice": 121.5, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 22, "totalCash": 29528000512, "totalCashPerShare": 7.376, "ebitda": 79138996224, "totalDebt": 41495998464, "quickRatio": 1.059, "currentRatio": 1.484, "totalRevenue": 367977005056, "debtToEquity": 20.047, "revenuePerShare": 89.25, "returnOnAssets": 0.10511, "returnOnEquity": 0.27201998, "grossProfits": 133715000000, "freeCashflow": 32003000320, "operatingCashflow": 67769999360, "earningsGrowth": -0.54, "revenueGrowth": -0.272, "grossMargins": 0.34379002, "ebitdaMargins": 0.21507, "operatingMargins": 0.12907, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "121 Albright Way", "city": "Los Gatos", "state": "CA", "zip": "95032", "country": "United States", "phone": "408 540 3700", "website": "https://www.netflix.com", "industry": "Entertainment", "industryKey": "entertainment", "industryDisp": "Entertainment", "sector": "Communication Services", "sectorKey": "communication-services", "sectorDisp": "Communication Services", "longBusinessSummary": "Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and mobile games across various genres and languages. The company provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes, and mobile devices. The company has approximately 231 million paid members in 190 countries. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.", "fullTimeEmployees": 12800, "companyOfficers": [{"maxAge": 1, "name": "Mr. Wilmot Reed Hastings Jr.", "age": 62, "title": "Co-Founder & Executive Chairman", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 1665055, "exercisedValue": 0, "unexercisedValue": 334580480}, {"maxAge": 1, "name": "Mr. Theodore A. Sarandos", "age": 57, "title": "Co-CEO, President & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 21786777, "exercisedValue": 0, "unexercisedValue": 66233184}, {"maxAge": 1, "name": "Mr. Gregory K. Peters", "age": 51, "title": "Co-CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 16617263, "exercisedValue": 0, "unexercisedValue": 18260940}, {"maxAge": 1, "name": "Mr. Spencer Adam Neumann", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 7038537, "exercisedValue": 0, "unexercisedValue": 3782964}, {"maxAge": 1, "name": "Mr. David  Hyman", "age": 56, "title": "Chief Legal Officer & Secretary", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 6012971, "exercisedValue": 0, "unexercisedValue": 18886556}, {"maxAge": 1, "name": "Ms. Rachel  Whetstone", "age": 54, "title": "Chief Communications Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 5502799, "exercisedValue": 0, "unexercisedValue": 533586}, {"maxAge": 1, "name": "Mr. Jeffrey William Karbowski", "age": 43, "title": "VP, Chief Accounting Officer & Principal Accounting Officer", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Stone", "title": "Chief Technology Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Spencer  Wang", "title": "Vice President of Finance, Corporate Development & Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marian  Lee", "age": 43, "title": "Chief Marketing Officer", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 6, "overallRisk": 10, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 373.32, "open": 372.775, "dayLow": 370.68, "dayHigh": 377.8, "regularMarketPreviousClose": 373.32, "regularMarketOpen": 372.775, "regularMarketDayLow": 370.68, "regularMarketDayHigh": 377.8, "payoutRatio": 0.0, "beta": 1.262, "trailingPE": 39.92455, "forwardPE": 24.570961, "volume": 1745963, "regularMarketVolume": 1745963, "averageVolume": 6006771, "averageVolume10days": 4907570, "averageDailyVolume10Day": 4907570, "bid": 373.17, "ask": 373.67, "bidSize": 1100, "askSize": 800, "marketCap": 166485901312, "fiftyTwoWeekLow": 211.73, "fiftyTwoWeekHigh": 485.0, "priceToSalesTrailing12Months": 5.182207, "fiftyDayAverage": 410.9428, "twoHundredDayAverage": 372.2362, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 173852246016, "profitMargins": 0.13217, "floatShares": 437221879, "sharesOutstanding": 443147008, "sharesShort": 8530217, "sharesShortPriorMonth": 8854933, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.019199999, "heldPercentInsiders": 0.01349, "heldPercentInstitutions": 0.83879995, "shortRatio": 1.75, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 458139008, "bookValue": 51.523, "priceToBook": 7.291695, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.032, "netIncomeToCommon": 4246256128, "trailingEps": 9.41, "forwardEps": 15.29, "pegRatio": 1.25, "lastSplitFactor": "7:1", "lastSplitDate": 1436918400, "enterpriseToRevenue": 5.411, "enterpriseToEbitda": 29.059, "52WeekChange": 0.690225, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NFLX", "underlyingSymbol": "NFLX", "shortName": "Netflix, Inc.", "longName": "Netflix, Inc.", "firstTradeDateEpochUtc": 1022160600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "1a1cddac-4d41-374d-b202-739314177b67", "messageBoardId": "finmb_32012", "gmtOffSetMilliseconds": -14400000, "currentPrice": 375.69, "targetHighPrice": 600.0, "targetLowPrice": 325.0, "targetMeanPrice": 465.47, "targetMedianPrice": 487.5, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 36, "totalCash": 8576989184, "totalCashPerShare": 19.355, "ebitda": 5982716928, "totalDebt": 16993690624, "quickRatio": 1.129, "currentRatio": 1.326, "totalRevenue": 32126445568, "debtToEquity": 74.429, "revenuePerShare": 72.226, "returnOnAssets": 0.07235, "returnOnEquity": 0.20265, "grossProfits": 12447265000, "freeCashflow": 17861232640, "operatingCashflow": 4619639808, "earningsGrowth": 0.028, "revenueGrowth": 0.027, "grossMargins": 0.38773, "ebitdaMargins": 0.18621999, "operatingMargins": 0.22317, "financialCurrency": "USD", "trailingPegRatio": 1.5155}, {"address1": "1400 Seaport Boulevard", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 503 2200", "website": "https://www.c3.ai", "industry": "Software - Application", "industryKey": "software-application", "industryDisp": "Software - Application", "sector": "Technology", "sectorKey": "technology", "sectorDisp": "Technology", "longBusinessSummary": "C3.ai, Inc. operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information. It also offers C3 AI applications, including C3 AI Inventory Optimization, a solution to optimize raw material, in-process, and finished goods inventory levels; C3 AI Supply Network Risk, which identifies emerging inbound and outbound risks across the network; C3 AI Sustainability Suite, which helps to decrease greenhouse gas emission; C3 AI Production Schedule Optimization, a solution for scheduling production; C3 AI Financial Services Suite, which helps to minimize compliance risks; and C3 AI Energy Management solution. In addition, it offers integrated turnkey enterprise AI applications for oil and gas, chemicals, utilities, manufacturing, financial services, defense, intelligence, aerospace, healthcare, and telecommunications market. It has strategic partnerships with Baker Hughes in the areas of oil and gas market; Booz Allen to provide solutions to government, defense, and intelligence sectors; Raytheon; and AWS, Google, and Microsoft. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.", "fullTimeEmployees": 914, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas M. Siebel", "age": 69, "title": "Founder, CEO & Chairman", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 2171867, "exercisedValue": 0, "unexercisedValue": 222951328}, {"maxAge": 1, "name": "Mr. Edward Y. Abbo", "age": 57, "title": "Pres & CTO", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1102682, "exercisedValue": 0, "unexercisedValue": 13189495}, {"maxAge": 1, "name": "Mr. Juho  Parkkinen", "age": 37, "title": "Sr. VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 790846, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Houman  Behzadi", "age": 43, "title": "Exec. VP", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1100990, "exercisedValue": 0, "unexercisedValue": 10385389}, {"maxAge": 1, "name": "Mr. Guy  Wanger", "age": 60, "title": "Sr. VP & Chief Admin. Officer", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Reuben  Gallegos", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Weber", "age": 58, "title": "Sr. VP & GM of AI Federal Systems", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lieutenant General Edward  Cardon", "title": "Member of Advisory Board and Chair of AI Federal Systems", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Major General Martin F. Klein", "title": "Sr. VP for Defense & Intelligence", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nikhil  Krishnan", "title": "Chief Technology Officer of Product", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 26.72, "open": 27.15, "dayLow": 26.65, "dayHigh": 27.47, "regularMarketPreviousClose": 26.72, "regularMarketOpen": 27.15, "regularMarketDayLow": 26.65, "regularMarketDayHigh": 27.47, "payoutRatio": 0.0, "beta": 1.535055, "forwardPE": -2733.1802, "volume": 3355865, "regularMarketVolume": 3355865, "averageVolume": 12717510, "averageVolume10days": 6085480, "averageDailyVolume10Day": 6085480, "bid": 26.94, "ask": 26.97, "bidSize": 1300, "askSize": 1400, "marketCap": 3230673408, "fiftyTwoWeekLow": 10.16, "fiftyTwoWeekHigh": 48.87, "priceToSalesTrailing12Months": 11.79728, "fiftyDayAverage": 29.6828, "twoHundredDayAverage": 26.78415, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 2173911552, "profitMargins": -0.95427, "floatShares": 99447872, "sharesOutstanding": 114702000, "sharesShort": 39175626, "sharesShortPriorMonth": 32965014, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.3314, "heldPercentInsiders": 0.10466, "heldPercentInstitutions": 0.47517, "shortRatio": 3.5, "shortPercentOfFloat": 0.4275, "impliedSharesOutstanding": 118202000, "bookValue": 7.907, "priceToBook": 3.4566586, "lastFiscalYearEnd": 1682812800, "nextFiscalYearEnd": 1714435200, "mostRecentQuarter": 1690761600, "netIncomeToCommon": -261326000, "trailingEps": -2.34, "forwardEps": -0.01, "pegRatio": -1.22, "enterpriseToRevenue": 7.938, "enterpriseToEbitda": -7.633, "52WeekChange": 1.2397318, "SandP52WeekChange": 0.2183963, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "AI", "underlyingSymbol": "AI", "shortName": "C3.ai, Inc.", "longName": "C3.ai, Inc.", "firstTradeDateEpochUtc": 1607524200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0a40e3c9-1a3a-35c9-a374-28c6d194d0e5", "messageBoardId": "finmb_24249083", "gmtOffSetMilliseconds": -14400000, "currentPrice": 27.3318, "targetHighPrice": 42.0, "targetLowPrice": 14.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.5, "recommendationMean": 3.1, "recommendationKey": "hold", "numberOfAnalystOpinions": 10, "totalCash": 750875008, "totalCashPerShare": 6.352, "ebitda": -284793984, "totalDebt": 4021000, "quickRatio": 7.889, "currentRatio": 8.082, "totalRevenue": 273848992, "debtToEquity": 0.431, "revenuePerShare": 2.444, "returnOnAssets": -0.16358, "returnOnEquity": -0.27344, "grossProfits": 180458000, "freeCashflow": -96277624, "operatingCashflow": -73497000, "revenueGrowth": 0.108, "grossMargins": 0.63577, "ebitdaMargins": -1.03997, "operatingMargins": -1.06401, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 52, "title": "CEO, Pres & Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 740950, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 56, "title": "Exec. VP & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 591225, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 42, "title": "VP of Strategy & Fin. and Sec.", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski", "age": 34, "title": "Corp. Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sharon  Sakai Ph.D., RAC", "title": "Head of Regulatory & Quality", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anne  Moon", "title": "Sr. VP and Head of Project Team Leadership, Project Management &  Portfolio Management", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.24, "open": 2.13, "dayLow": 1.82, "dayHigh": 2.54, "regularMarketPreviousClose": 0.24, "regularMarketOpen": 2.13, "regularMarketDayLow": 1.82, "regularMarketDayHigh": 2.54, "payoutRatio": 0.0, "beta": 1.397495, "forwardPE": -1.359375, "volume": 89344647, "regularMarketVolume": 89344647, "averageVolume": 542295, "averageVolume10days": 2673210, "averageDailyVolume10Day": 2673210, "bid": 0.0, "ask": 0.0, "bidSize": 1400, "askSize": 1300, "marketCap": 28979916, "fiftyTwoWeekLow": 0.17, "fiftyTwoWeekHigh": 4.214, "fiftyDayAverage": 0.52882, "twoHundredDayAverage": 1.401825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 6940535, "profitMargins": 0.0, "floatShares": 7775658, "sharesOutstanding": 13324100, "sharesShort": 84968, "sharesShortPriorMonth": 14201, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0064, "heldPercentInsiders": 0.03, "heldPercentInstitutions": 0.68917, "shortRatio": 0.5, "shortPercentOfFloat": 0.0095999995, "impliedSharesOutstanding": 13324100, "bookValue": 0.398, "priceToBook": 5.464824, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -33267000, "trailingEps": -2.0, "forwardEps": -1.6, "lastSplitFactor": "1:15", "lastSplitDate": 1624838400, "enterpriseToEbitda": -0.216, "52WeekChange": -0.84810126, "SandP52WeekChange": 0.2183963, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TPST", "underlyingSymbol": "TPST", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "firstTradeDateEpochUtc": 1352730600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d54d822e-cd83-39cb-b46d-5c9b6edb9502", "messageBoardId": "finmb_552715229", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.175, "targetHighPrice": 35.0, "targetLowPrice": 4.0, "targetMeanPrice": 15.67, "targetMedianPrice": 8.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 17604000, "totalCashPerShare": 1.321, "ebitda": -32130000, "totalDebt": 21480000, "quickRatio": 2.038, "currentRatio": 2.146, "debtToEquity": 428.571, "returnOnAssets": -0.40105, "returnOnEquity": -1.6656799, "freeCashflow": -19039500, "operatingCashflow": -30246000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "660 West Germantown Pike", "address2": "Suite 110", "city": "Plymouth Meeting", "state": "PA", "zip": "19462", "country": "United States", "phone": "267 440 4200", "fax": "267 440 4242", "website": "https://www.inovio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.", "fullTimeEmployees": 135, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jacqueline E. Shea Ph.D.", "age": 56, "title": "CEO, Pres & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 1079282, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter D. Kies", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 688724, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurent M. Humeau Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 673589, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Hong", "title": "Mang. of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert L. Crotty J.D.", "age": 48, "title": "Gen. Counsel & Chief Compliance Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. E. J. Brandreth MBA", "title": "Sr. VP of Quality Assurance", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Skolnik", "title": "Sr. VP of Clinical Devel.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Juba Jr.", "title": "Sr. VP of Biological Manufacturing & Clinical Supply Management", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Kemmerrer M.B.A., P.E.", "title": "Sr. VP of Engineering Devel.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn D. Bridy M.A., M.B.A., MA, MBA", "title": "Sr. VP of Bus. Devel.", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 3, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.5062, "open": 0.54, "dayLow": 0.5002, "dayHigh": 0.55, "regularMarketPreviousClose": 0.5062, "regularMarketOpen": 0.54, "regularMarketDayLow": 0.5002, "regularMarketDayHigh": 0.55, "payoutRatio": 0.0, "beta": 0.981679, "forwardPE": -1.5224241, "volume": 5031610, "regularMarketVolume": 5031610, "averageVolume": 3181257, "averageVolume10days": 6826650, "averageDailyVolume10Day": 6826650, "bid": 0.515, "ask": 0.5198, "bidSize": 1800, "askSize": 1100, "marketCap": 134680880, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 2.61, "priceToSalesTrailing12Months": 14.000509, "fiftyDayAverage": 0.4256, "twoHundredDayAverage": 0.85255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": -28464130, "profitMargins": 0.0, "floatShares": 263683803, "sharesOutstanding": 268075008, "sharesShort": 14895664, "sharesShortPriorMonth": 16701502, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0556, "heldPercentInsiders": 0.01638, "heldPercentInstitutions": 0.36571997, "shortRatio": 7.16, "shortPercentOfFloat": 0.0634, "impliedSharesOutstanding": 268075008, "bookValue": 0.632, "priceToBook": 0.79493666, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -168430880, "trailingEps": -0.89, "forwardEps": -0.33, "pegRatio": -0.02, "lastSplitFactor": "1:4", "lastSplitDate": 1402012800, "enterpriseToRevenue": -2.959, "enterpriseToEbitda": 0.168, "52WeekChange": -0.68711656, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "INO", "underlyingSymbol": "INO", "shortName": "Inovio Pharmaceuticals, Inc.", "longName": "Inovio Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 913127400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ac020a93-0ebc-3108-95e6-c7f296b9daee", "messageBoardId": "finmb_28922", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.5024, "targetHighPrice": 2.0, "targetLowPrice": 0.5, "targetMeanPrice": 1.25, "targetMedianPrice": 1.25, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 2, "totalCash": 194925456, "totalCashPerShare": 0.727, "ebitda": -169114496, "totalDebt": 30761822, "quickRatio": 3.852, "currentRatio": 3.914, "totalRevenue": 9619713, "debtToEquity": 18.162, "revenuePerShare": 0.038, "returnOnAssets": -0.31175, "returnOnEquity": -0.72126, "grossProfits": -177388235, "freeCashflow": -126737896, "operatingCashflow": -172784480, "revenueGrowth": -0.712, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -17.95235, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "22, Avenue Montaigne", "city": "Paris", "zip": "75008", "country": "France", "phone": "33 1 44 13 22 22", "fax": "33 1 44 13 21 19", "website": "https://www.lvmh.com", "industry": "Luxury Goods", "industryKey": "luxury-goods", "industryDisp": "Luxury Goods", "sector": "Consumer Cyclical", "sectorKey": "consumer-cyclical", "sectorDisp": "Consumer Cyclical", "longBusinessSummary": "LVMH Mo\u00ebt Hennessy - Louis Vuitton, Soci\u00e9t\u00e9 Europ\u00e9enne operates as a luxury goods company worldwide. The company offers champagnes, wines, and spirits under the Clos des Lambrays, Ch\u00e2teau d'Yquem, Dom P\u00e9rignon, Ruinart, Mo\u00ebt & Chandon, Hennessy, Veuve Clicquot, Ch\u00e2teau Galoupet, Ardbeg, Ch\u00e2teau Cheval Blanc, Glenmorangie, Krug, Mercier, Chandon, Cape Mentelle, Joseph Phelps, Newton Vineyard, Cloudy Bay, Belvedere, Terrazas de los Andes, Bodega Numanthia, Cheval des Andes, Woodinville, Ao Yun, Clos19, Volcan de mi Tierra, and Eminente brands; and fashion and leather products under the Loewe, Moynat, Louis Vuitton, Berluti, RIMOWA, Patou, Loro Piana, FENDI, Celine, Christian Dior, Emilio Pucci, Givenchy, Kenzo, and Marc Jacobs brands. It also provides perfumes and cosmetics under the Stella by Stella Mccartney, Officine Universelle Buly, Guerlain, Acqua di Parma, Parfums Christian Dior, Givenchy Parfums, Perfumes Loewe, Benefit Cosmetics, Make Up For Ever, Kenzo Parfums, Fresh, KVD Beauty, Maison Francis Kurkdjian, Cha Ling, Fenty Beauty by Rihanna, and Marc Jacobs brands; watches and jewelry under the Chaumet, Tiffany & Co., TAG Heuer, Zenith, Bulgari, Fred, Hublot, and Repossi brands; and custom-designed yachts under the Feadship and Cheval Blanc brand names, as well as designs and builds luxury yachts under the Royal Van Lent brand. In addition, the company offers daily newspapers under the Les \u00c9chos brand; Belmond, a luxury tourism service; home other activities under the Cova, Jardin d'Acclimatation, Le Parisien, Connaissance des Arts, Investir, and Radio Classique brands; and selective retailing products under the DFS, La Grande Epicerie de Paris, Le Bon March\u00e9 Rive Gauche, Sephora, and Starboard Cruise Services brands, as well as operates Jardin d'Acclimatation, a leisure and theme park. It operates 5,664 stores. LVMH Mo\u00ebt Hennessy - Louis Vuitton, Soci\u00e9t\u00e9 Europ\u00e9enne was incorporated in 1923 and is headquartered in Paris, France", "fullTimeEmployees": 173492, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bernard  Arnault", "age": 73, "title": "Chairman & CEO", "yearBorn": 1949, "fiscalYear": 2022, "totalPay": 3457638, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicolas  Bazire", "age": 65, "title": "Senior VP of Development & Acquisitions and Director", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 3983059, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antonio  Belloni", "age": 68, "title": "Group MD & Director", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": 6199902, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antoine  Arnault", "age": 45, "title": "Group Chief Image & Environment Officer and Director", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": 1323171, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Jacques  Guiony", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Bernard  Kuhn", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yann  Bouillonnec", "title": "Vice President of Sales", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Chantal  Gaemperle", "age": 60, "title": "Group Executive Vice President of Human Resources & Synergies", "yearBorn": 1962, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shantanu  Mukherji", "title": "Managing Director od L Catterton", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  de Lapuente", "age": 59, "title": "Chairman & CEO of Selective Retailing Division", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 733.5, "open": 691.0, "dayLow": 671.5, "dayHigh": 699.2, "regularMarketPreviousClose": 733.5, "regularMarketOpen": 691.0, "regularMarketDayLow": 671.5, "regularMarketDayHigh": 699.2, "dividendRate": 12.0, "dividendYield": 0.0164, "exDividendDate": 1682380800, "payoutRatio": 0.3754, "fiveYearAvgDividendYield": 1.39, "beta": 1.019, "trailingPE": 21.751095, "forwardPE": 19.840273, "volume": 908811, "regularMarketVolume": 908811, "averageVolume": 363686, "averageVolume10days": 382349, "averageDailyVolume10Day": 382349, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 347381235712, "fiftyTwoWeekLow": 595.3, "fiftyTwoWeekHigh": 904.6, "priceToSalesTrailing12Months": 4.1015553, "fiftyDayAverage": 762.154, "twoHundredDayAverage": 810.0455, "trailingAnnualDividendRate": 12.5, "trailingAnnualDividendYield": 0.01704158, "currency": "EUR", "enterpriseValue": 396026609664, "profitMargins": 0.1893, "floatShares": 256926722, "sharesOutstanding": 499398016, "heldPercentInsiders": 0.48389998, "heldPercentInstitutions": 0.21426001, "impliedSharesOutstanding": 499398016, "bookValue": 115.57, "priceToBook": 6.0188627, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.298, "netIncomeToCommon": 16033000448, "trailingEps": 31.98, "forwardEps": 35.06, "pegRatio": 2.15, "lastSplitFactor": "5:1", "lastSplitDate": 962582400, "enterpriseToRevenue": 4.676, "enterpriseToEbitda": 15.714, "52WeekChange": 0.17945004, "SandP52WeekChange": 0.2183963, "lastDividendValue": 7.0, "lastDividendDate": 1682380800, "exchange": "PAR", "quoteType": "EQUITY", "symbol": "MC.PA", "underlyingSymbol": "MC.PA", "shortName": "LVMH", "longName": "LVMH Mo\u00ebt Hennessy - Louis Vuitton, Soci\u00e9t\u00e9 Europ\u00e9enne", "firstTradeDateEpochUtc": 946886400, "timeZoneFullName": "Europe/Paris", "timeZoneShortName": "CEST", "uuid": "ccc1da86-1846-32b6-8744-bc05d234a5f4", "messageBoardId": "finmb_195488", "gmtOffSetMilliseconds": 7200000, "currentPrice": 695.6, "targetHighPrice": 1020.0, "targetLowPrice": 730.0, "targetMeanPrice": 891.5, "targetMedianPrice": 882.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 29, "totalCash": 10382000128, "totalCashPerShare": 20.789, "ebitda": 25201999872, "totalDebt": 38358999040, "quickRatio": 0.51, "currentRatio": 1.225, "totalRevenue": 84694999040, "debtToEquity": 64.524, "revenuePerShare": 169.047, "returnOnAssets": 0.10329001, "returnOnEquity": 0.29794002, "grossProfits": 54196000000, "freeCashflow": 8326000128, "operatingCashflow": 17316999168, "earningsGrowth": 0.303, "revenueGrowth": 0.15, "grossMargins": 0.6872, "ebitdaMargins": 0.29756, "operatingMargins": 0.2742, "financialCurrency": "EUR", "trailingPegRatio": 2.3952}, {"address1": "Novo Alle 1", "city": "Bagsvaerd", "zip": "2880", "country": "Denmark", "phone": "45 44 44 88 88", "website": "https://www.novonordisk.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.", "fullTimeEmployees": 59337, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lars Fruergaard Jorgensen", "age": 56, "title": "President, CEO & Member of Management Board", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 32300000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Karsten Munk Knudsen", "age": 51, "title": "Executive VP, CFO & Member of the Management Board", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 12800000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik Ehlers Wulff", "age": 52, "title": "Executive VP of Product Supply, Quality & IT and Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 12900000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Camilla  Sylvest", "age": 50, "title": "Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 12600000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martin Holst Lange", "age": 52, "title": "Executive VP of Development & Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 12200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marcus  Schindler Ph.D.", "age": 56, "title": "EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 12200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maziar Mike Doustdar", "age": 52, "title": "Executive VP of International Operations & Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Langa", "age": 56, "title": "Executive VP of North America Operations & Member of Management Board", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ludovic  Helfgott", "age": 48, "title": "Executive VP, Head of Rare Disease & Member of Management Board", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tania  Sabroe", "title": "Executive VP of Global People & Organisation and Member of Management Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 1, "shareHolderRightsRisk": 10, "overallRisk": 2, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 93.01, "open": 96.5, "dayLow": 95.02, "dayHigh": 97.02, "regularMarketPreviousClose": 93.01, "regularMarketOpen": 96.5, "regularMarketDayLow": 95.02, "regularMarketDayHigh": 97.02, "dividendRate": 1.03, "dividendYield": 0.0111, "exDividendDate": 1692316800, "payoutRatio": 0.4149, "fiveYearAvgDividendYield": 1.8, "beta": 0.21, "trailingPE": 45.810432, "forwardPE": 38.05512, "volume": 3248972, "regularMarketVolume": 3248972, "averageVolume": 3867495, "averageVolume10days": 4171970, "averageDailyVolume10Day": 4171970, "bid": 96.91, "ask": 96.93, "bidSize": 900, "askSize": 800, "marketCap": 428517949440, "fiftyTwoWeekLow": 50.445, "fiftyTwoWeekHigh": 100.88, "priceToSalesTrailing12Months": 2.1284885, "fiftyDayAverage": 91.8504, "twoHundredDayAverage": 80.24362, "trailingAnnualDividendRate": 7.075, "trailingAnnualDividendYield": 0.07606708, "currency": "USD", "enterpriseValue": 406948118528, "profitMargins": 0.33398, "floatShares": 3215036592, "sharesOutstanding": 4433249792, "sharesShort": 5913493, "sharesShortPriorMonth": 3894354, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0013, "heldPercentInsiders": 7e-05, "heldPercentInstitutions": 0.082229994, "shortRatio": 1.38, "impliedSharesOutstanding": 4472000000, "bookValue": 20.185, "priceToBook": 4.788705, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.459, "netIncomeToCommon": 67238998016, "trailingEps": 2.11, "forwardEps": 2.54, "pegRatio": 106.9, "lastSplitFactor": "2:1", "lastSplitDate": 1695168000, "enterpriseToRevenue": 2.021, "enterpriseToEbitda": 4.381, "52WeekChange": 0.7889979, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.884, "lastDividendDate": 1692316800, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "NVO", "underlyingSymbol": "NVO", "shortName": "Novo Nordisk A/S", "longName": "Novo Nordisk A/S", "firstTradeDateEpochUtc": 357485400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ec4e324f-1461-36f1-bb32-2ca54d8984b3", "messageBoardId": "finmb_323452", "gmtOffSetMilliseconds": -14400000, "currentPrice": 96.66, "targetHighPrice": 105.72, "targetLowPrice": 58.4, "targetMeanPrice": 80.55, "targetMedianPrice": 77.52, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 36408000512, "totalCashPerShare": 8.108, "ebitda": 92893003776, "totalDebt": 25703999488, "quickRatio": 0.683, "currentRatio": 0.878, "totalRevenue": 201325002752, "debtToEquity": 28.411, "revenuePerShare": 44.689, "returnOnAssets": 0.21757999, "returnOnEquity": 0.81539, "grossProfits": 148506000000, "freeCashflow": 53321375744, "operatingCashflow": 89730998272, "earningsGrowth": 0.473, "revenueGrowth": 0.316, "grossMargins": 0.84353995, "ebitdaMargins": 0.46141, "operatingMargins": 0.43993, "financialCurrency": "DKK", "trailingPegRatio": 5.406}, {"address1": "Lilly Corporate Center", "city": "Indianapolis", "state": "IN", "zip": "46285", "country": "United States", "phone": "317 276 2000", "website": "https://www.lilly.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.", "fullTimeEmployees": 39000, "companyOfficers": [{"maxAge": 1, "name": "Mr. David A. Ricks", "age": 54, "title": "Chairman, CEO & President", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 4416885, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anat  Ashkenazi", "age": 49, "title": "Executive VP & CFO", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 2125270, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel M. Skovronsky M.D., Ph.D.", "age": 48, "title": "Executive VP, Chief Scientific & Medical Officer and President of Lilly Research Laboratories", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 2716346, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anat  Hakim J.D.", "age": 53, "title": "Executive VP, General Counsel & Secretary", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 1979674, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrik  Jonsson", "age": 55, "title": "EVP, Chief Customer Officer, President of Lilly USA & Lilly Immunology", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 1673270, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Donald A. Zakrowski", "title": "Chief Accounting Officer & VP of Finance", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Diogo  Rau", "title": "EVP & Chief Information and Digital Officer", "fiscalYear": 2022, "totalPay": 1056809, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alonzo  Weems", "age": 51, "title": "EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leigh Ann Pusey", "age": 59, "title": "Executive Vice President of Corporate Affairs & Communications", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Dozier", "age": 55, "title": "Executive Vice President of Human Resources & Diversity", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 5, "compensationRisk": 1, "shareHolderRightsRisk": 9, "overallRisk": 5, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 579.31, "open": 596.2, "dayLow": 585.01, "dayHigh": 605.485, "regularMarketPreviousClose": 579.31, "regularMarketOpen": 596.2, "regularMarketDayLow": 585.01, "regularMarketDayHigh": 605.485, "dividendRate": 4.52, "dividendYield": 0.0078, "exDividendDate": 1691971200, "payoutRatio": 0.5877, "fiveYearAvgDividendYield": 1.57, "beta": 0.331, "trailingPE": 83.633705, "forwardPE": 47.58241, "volume": 1485337, "regularMarketVolume": 1485337, "averageVolume": 2886965, "averageVolume10days": 3086260, "averageDailyVolume10Day": 3086260, "bid": 604.03, "ask": 604.21, "bidSize": 800, "askSize": 800, "marketCap": 570042155008, "fiftyTwoWeekLow": 309.2, "fiftyTwoWeekHigh": 605.485, "priceToSalesTrailing12Months": 19.313316, "fiftyDayAverage": 544.8056, "twoHundredDayAverage": 427.117, "trailingAnnualDividendRate": 4.22, "trailingAnnualDividendYield": 0.0072845276, "currency": "USD", "enterpriseValue": 537068371968, "profitMargins": 0.22014, "floatShares": 897487590, "sharesOutstanding": 949294976, "sharesShort": 5654300, "sharesShortPriorMonth": 5617552, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.006, "heldPercentInsiders": 0.00153, "heldPercentInstitutions": 0.83985, "shortRatio": 2.0, "shortPercentOfFloat": 0.0070999996, "impliedSharesOutstanding": 949294976, "bookValue": 12.303, "priceToBook": 48.80842, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.851, "netIncomeToCommon": 6497500160, "trailingEps": 7.18, "forwardEps": 12.62, "pegRatio": 2.25, "lastSplitFactor": "2:1", "lastSplitDate": 876960000, "enterpriseToRevenue": 18.196, "enterpriseToEbitda": 54.999, "52WeekChange": 0.7848538, "SandP52WeekChange": 0.2183963, "lastDividendValue": 1.13, "lastDividendDate": 1691971200, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "LLY", "underlyingSymbol": "LLY", "shortName": "Eli Lilly and Company", "longName": "Eli Lilly and Company", "firstTradeDateEpochUtc": 76253400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7b37be39-dfde-3602-b0e4-4d76cf52143b", "messageBoardId": "finmb_285467", "gmtOffSetMilliseconds": -14400000, "currentPrice": 600.49, "targetHighPrice": 700.0, "targetLowPrice": 340.0, "targetMeanPrice": 586.28, "targetMedianPrice": 600.0, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 24, "totalCash": 2941299968, "totalCashPerShare": 3.271, "ebitda": 9765000192, "totalDebt": 18953500672, "quickRatio": 0.633, "currentRatio": 1.128, "totalRevenue": 29515499520, "debtToEquity": 169.997, "revenuePerShare": 32.763, "returnOnAssets": 0.10182, "returnOnEquity": 0.65602994, "grossProfits": 21911600000, "freeCashflow": 5056487424, "operatingCashflow": 5740599808, "earningsGrowth": 0.857, "revenueGrowth": 0.281, "grossMargins": 0.77769995, "ebitdaMargins": 0.33084, "operatingMargins": 0.28132, "financialCurrency": "USD", "trailingPegRatio": 1.5259}, {"address1": "1-2 Berkeley Square", "city": "London", "zip": "W1J 6EA", "country": "United Kingdom", "phone": "44 1534 835 600", "website": "https://www.birkenstock.com", "industry": "Footwear & Accessories", "industryKey": "footwear-accessories", "industryDisp": "Footwear & Accessories", "sector": "Consumer Cyclical", "sectorKey": "consumer-cyclical", "sectorDisp": "Consumer Cyclical", "longBusinessSummary": "Birkenstock Holding Limited manufactures and sells footwear products. It offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories for men, women, and kids. The company sells its products through online and retail stores. It operates in the Americas, Europe, the Asia Pacific, the Middle East, and Africa. The company was formerly known as Birkenstock Group Limited and changed its name to Birkenstock Holding Limited in July 2023. Birkenstock Holding Limited was founded in 1774 and is based in London, the United Kingdom. Birkenstock Holding Limited operates as a subsidiary of Bk Lc Lux Midco S.\u00e0 R.l.", "fullTimeEmployees": 4800, "companyOfficers": [{"maxAge": 1, "name": "Mr. Oliver  Reichert", "age": 51, "title": "CEO & Director", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Erik  Massmann", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Jensen", "age": 39, "title": "Chief Technical Operations Officer", "yearBorn": 1983, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian  Heesch", "age": 49, "title": "Chief Legal Officer", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jochen  Gutzy", "age": 52, "title": "Chief Communications Officer", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Klaus  Baumann", "age": 53, "title": "Chief Sales Officer", "yearBorn": 1969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Markus  Baum", "age": 44, "title": "Chief Product Officer", "yearBorn": 1978, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Kahan", "age": 61, "title": "Pres of Americas", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mehdi Nico Bouyakhf", "age": 47, "title": "Pres of Europe", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 46.0, "dayLow": 46.0, "dayHigh": 46.0, "regularMarketPreviousClose": 46.0, "regularMarketDayLow": 46.0, "regularMarketDayHigh": 46.0, "fiftyTwoWeekLow": 46.0, "fiftyTwoWeekHigh": 46.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 10161739776, "profitMargins": 0.11209, "bookValue": 12.985, "priceToBook": 3.5425491, "lastFiscalYearEnd": 1664496000, "nextFiscalYearEnd": 1696032000, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.134, "netIncomeToCommon": 161288992, "enterpriseToRevenue": 7.062, "enterpriseToEbitda": 21.604, "SandP52WeekChange": 0.2183963, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "BIRK", "underlyingSymbol": "BIRK", "shortName": "Birkenstock Holding plc", "longName": "Birkenstock Holding Limited", "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a10d276b-4c9e-3e35-b79a-413306ef479c", "messageBoardId": "finmb_1848618564", "gmtOffSetMilliseconds": -14400000, "currentPrice": 46.0, "recommendationKey": "none", "totalCash": 289608992, "totalCashPerShare": 1.585, "ebitda": 470364992, "totalDebt": 1954804992, "quickRatio": 1.215, "currentRatio": 2.829, "totalRevenue": 1438976000, "debtToEquity": 82.389, "revenuePerShare": 7.875, "grossProfits": 774169000, "operatingCashflow": 367100992, "earningsGrowth": 0.134, "revenueGrowth": 0.25, "grossMargins": 0.63312, "ebitdaMargins": 0.32687, "operatingMargins": 0.26639998, "financialCurrency": "EUR", "trailingPegRatio": null}, {"address1": "1202 BMC Drive", "address2": "Suite 100", "city": "Cedar Park", "state": "TX", "zip": "78613", "country": "United States", "phone": "833 495 4466", "website": "https://www.hyliion.com", "industry": "Auto Parts", "industryKey": "auto-parts", "industryDisp": "Auto Parts", "sector": "Consumer Cyclical", "sectorKey": "consumer-cyclical", "sectorDisp": "Consumer Cyclical", "longBusinessSummary": "Hyliion Holdings Corp. designs, develops, and sells electrified powertrain solutions for the commercial vehicle industry. It offers battery management systems for hybrid and fully electric vehicle applications; and battery packs. The company was founded in 2015 and is headquartered in Cedar Park, Texas.", "fullTimeEmployees": 250, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas J. Healy", "age": 29, "title": "Founder, Pres, CEO & Director", "yearBorn": 1993, "fiscalYear": 2022, "totalPay": 1190310, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon T. Panzer", "title": "Chief Financial Officer", "fiscalYear": 2022, "totalPay": 565128, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dennis M. Gallagher", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": 811720, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jose Miguel Oxholm", "age": 55, "title": "VP, Gen. Counsel & Chief Compliance Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 553660, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cheri L. Lantz", "title": "Chief Strategy Officer", "fiscalYear": 2022, "totalPay": 605045, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Sexton", "age": 48, "title": "Chief Technology Officer", "yearBorn": 1974, "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Adam  Bresser", "title": "Sr. Director of Financial Planning & Analysis and Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.19, "open": 0.93, "dayLow": 0.6312, "dayHigh": 0.93, "regularMarketPreviousClose": 1.19, "regularMarketOpen": 0.93, "regularMarketDayLow": 0.6312, "regularMarketDayHigh": 0.93, "payoutRatio": 0.0, "beta": 1.460983, "forwardPE": -0.7793827, "volume": 5809671, "regularMarketVolume": 5809671, "averageVolume": 1354743, "averageVolume10days": 1045850, "averageDailyVolume10Day": 1045850, "bid": 0.6511, "ask": 0.6521, "bidSize": 1000, "askSize": 1100, "marketCap": 114404184, "fiftyTwoWeekLow": 0.6312, "fiftyTwoWeekHigh": 3.88, "priceToSalesTrailing12Months": 52.72082, "fiftyDayAverage": 1.2954, "twoHundredDayAverage": 1.9657, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": -7325751, "profitMargins": 0.0, "floatShares": 125785064, "sharesOutstanding": 181220000, "sharesShort": 10055756, "sharesShortPriorMonth": 10492373, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0555, "heldPercentInsiders": 0.31535998, "heldPercentInstitutions": 0.31876, "shortRatio": 7.82, "shortPercentOfFloat": 0.0686, "impliedSharesOutstanding": 181220000, "bookValue": 2.005, "priceToBook": 0.31486282, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -156832000, "trailingEps": -0.97, "forwardEps": -0.81, "enterpriseToRevenue": -3.376, "enterpriseToEbitda": 0.044, "52WeekChange": -0.53149605, "SandP52WeekChange": 0.2183963, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "HYLN", "underlyingSymbol": "HYLN", "shortName": "Hyliion Holdings Corp.", "longName": "Hyliion Holdings Corp.", "firstTradeDateEpochUtc": 1577975400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ca2725d5-d55d-3f0e-92cf-9946e76199dc", "messageBoardId": "finmb_381114489", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.6313, "targetHighPrice": 2.8, "targetLowPrice": 1.25, "targetMeanPrice": 2.01, "targetMedianPrice": 2.0, "recommendationMean": 3.2, "recommendationKey": "hold", "numberOfAnalystOpinions": 4, "totalCash": 231644992, "totalCashPerShare": 1.278, "ebitda": -166595008, "totalDebt": 8667000, "quickRatio": 12.608, "currentRatio": 13.517, "totalRevenue": 2170000, "debtToEquity": 2.387, "revenuePerShare": 0.012, "returnOnAssets": -0.23095, "returnOnEquity": -0.36477003, "grossProfits": -6672000, "freeCashflow": -121942496, "operatingCashflow": -124895000, "revenueGrowth": 0.547, "grossMargins": -1.54931, "ebitdaMargins": 0.0, "operatingMargins": -77.557594, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "2000 16th Street", "city": "Denver", "state": "CO", "zip": "80202", "country": "United States", "phone": "720 631 2100", "website": "https://www.davita.com", "industry": "Medical Care Facilities", "industryKey": "medical-care-facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.", "fullTimeEmployees": 70000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Javier J. Rodriguez", "age": 51, "title": "CEO & Exec. Director", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 2984581, "exercisedValue": 2494759, "unexercisedValue": 9326725}, {"maxAge": 1, "name": "Mr. Joel  Ackerman", "age": 57, "title": "CFO & Treasurer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 1192925, "exercisedValue": 0, "unexercisedValue": 1696144}, {"maxAge": 1, "name": "Ms. Kathleen Alyce Waters", "age": 54, "title": "Chief Legal & Public Affairs Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 1077714, "exercisedValue": 653403, "unexercisedValue": 1173510}, {"maxAge": 1, "name": "Mr. James O. Hearty", "age": 53, "title": "Chief Compliance Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 768286, "exercisedValue": 101320, "unexercisedValue": 776693}, {"maxAge": 1, "name": "Mr. Michael David Staffieri", "age": 48, "title": "Chief Operating Officer of Kidney Care", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 1653896, "exercisedValue": 0, "unexercisedValue": 4270670}, {"maxAge": 1, "name": "Mr. Christopher Michael Berry", "age": 47, "title": "Group VP & Chief Accounting Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Gustafson", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth Gardner Smith", "age": 41, "title": "Chief People Officer", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Misha  Palecek", "title": "Chief Transformation Officer of U.S. Kidney Care Bus.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey Allen Giullian", "title": "Chief Medical Officer of Kidney Care", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 2, "compensationRisk": 9, "shareHolderRightsRisk": 3, "overallRisk": 5, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 91.28, "open": 76.2, "dayLow": 74.791, "dayHigh": 78.0, "regularMarketPreviousClose": 91.28, "regularMarketOpen": 76.2, "regularMarketDayLow": 74.791, "regularMarketDayHigh": 78.0, "payoutRatio": 0.0, "beta": 0.953335, "trailingPE": 14.885215, "forwardPE": 9.808974, "volume": 2422911, "regularMarketVolume": 2422911, "averageVolume": 718992, "averageVolume10days": 819090, "averageDailyVolume10Day": 819090, "bid": 76.3, "ask": 76.31, "bidSize": 800, "askSize": 800, "marketCap": 6985362944, "fiftyTwoWeekLow": 65.28, "fiftyTwoWeekHigh": 116.97, "priceToSalesTrailing12Months": 0.5950738, "fiftyDayAverage": 100.1914, "twoHundredDayAverage": 91.1642, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 21084323840, "profitMargins": 0.039839998, "floatShares": 54321674, "sharesOutstanding": 91300000, "sharesShort": 3571745, "sharesShortPriorMonth": 2886869, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.039100002, "heldPercentInsiders": 0.03234, "heldPercentInstitutions": 0.90032, "shortRatio": 4.51, "shortPercentOfFloat": 0.0655, "impliedSharesOutstanding": 91300000, "bookValue": 11.148, "priceToBook": 6.863115, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": -0.205, "netIncomeToCommon": 454255008, "trailingEps": 5.14, "forwardEps": 7.8, "pegRatio": 1.05, "lastSplitFactor": "2:1", "lastSplitDate": 1378684800, "enterpriseToRevenue": 1.796, "enterpriseToEbitda": 10.492, "52WeekChange": 0.043915868, "SandP52WeekChange": 0.2183963, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "DVA", "underlyingSymbol": "DVA", "shortName": "DaVita Inc.", "longName": "DaVita Inc.", "firstTradeDateEpochUtc": 815149800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9a98f945-67ed-31a1-b380-e8d4ee6cc270", "messageBoardId": "finmb_35644", "gmtOffSetMilliseconds": -14400000, "currentPrice": 76.51, "targetHighPrice": 142.0, "targetLowPrice": 100.0, "targetMeanPrice": 114.83, "targetMedianPrice": 112.5, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 6, "totalCash": 339927008, "totalCashPerShare": 3.723, "ebitda": 2009592960, "totalDebt": 11478210560, "quickRatio": 1.126, "currentRatio": 1.249, "totalRevenue": 11738649600, "debtToEquity": 436.497, "revenuePerShare": 129.463, "returnOnAssets": 0.04622, "returnOnEquity": 0.29011, "grossProfits": 3400341000, "freeCashflow": 1168644352, "operatingCashflow": 1966918016, "earningsGrowth": -0.17, "revenueGrowth": 0.025, "grossMargins": 0.29393, "ebitdaMargins": 0.17119, "operatingMargins": 0.10727999, "financialCurrency": "USD", "trailingPegRatio": 0.7391}, {"address1": "14901 South Orange Blossom Trail", "city": "Orlando", "state": "FL", "zip": "32837", "country": "United States", "phone": "407 826 5050", "website": "https://www.tupperwarebrands.com", "industry": "Packaging & Containers", "industryKey": "packaging-containers", "industryDisp": "Packaging & Containers", "sector": "Consumer Cyclical", "sectorKey": "consumer-cyclical", "sectorDisp": "Consumer Cyclical", "longBusinessSummary": "Tupperware Brands Corporation operates as a consumer products company worldwide. The company manufactures, markets, and sells design-centric preparation, storage, and serving solutions for the kitchen and home, as well as a line of cookware, knives, microwave products, microfiber textiles, water-filtration related items, and an array of products for on-the-go consumers under the Tupperware brand name. It distributes its products to approximately 70 countries primarily through independent sales force members, including independent distributors, directors, managers, and dealers. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. Tupperware Brands Corporation was founded in 1946 and is headquartered in Orlando, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Miguel Angel Fernandez", "age": 50, "title": "Pres, CEO & Director", "yearBorn": 1972, "fiscalYear": 2021, "totalPay": 2433621, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard P. Goudis", "age": 61, "title": "Exec. Vice Chairman", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": 0, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hector  Lezama", "title": "Chief Commercial Officer", "fiscalYear": 2021, "totalPay": 707991, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mariela Irene Matute", "age": 45, "title": "Exec. VP & CFO", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas Matthai Lane C.F.A.", "title": "VP of Investor Relations & Strategy", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Luis  Vazquez", "title": "Sr. VP of Sales & Marketing", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beatriz  D\u00edaz de la Fuente", "title": "Exec. VP & Chief HR Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Van Ingen", "title": "Exec. VP of Supply Chain", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian J. Fox", "age": 56, "title": "Chief Restructuring Officer", "yearBorn": 1966, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nguyen  Lien", "title": "Director Financial Reporting", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 1, "compensationRisk": 3, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.5, "open": 1.72, "dayLow": 1.69, "dayHigh": 2.04, "regularMarketPreviousClose": 1.5, "regularMarketOpen": 1.72, "regularMarketDayLow": 1.69, "regularMarketDayHigh": 2.04, "exDividendDate": 1568678400, "payoutRatio": 0.0, "beta": 2.984099, "forwardPE": 2.195542, "volume": 15616895, "regularMarketVolume": 15616895, "averageVolume": 22411898, "averageVolume10days": 2574510, "averageDailyVolume10Day": 2574510, "bid": 1.9, "ask": 1.91, "bidSize": 900, "askSize": 1200, "marketCap": 81052256, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 8.0, "priceToSalesTrailing12Months": 0.062080465, "fiftyDayAverage": 2.5084, "twoHundredDayAverage": 2.352, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 647364992, "profitMargins": -0.010880001, "floatShares": 38810675, "sharesOutstanding": 44478000, "sharesShort": 8019700, "sharesShortPriorMonth": 8675646, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.18030001, "heldPercentInsiders": 0.1129, "heldPercentInstitutions": 0.60817003, "shortRatio": 1.33, "shortPercentOfFloat": 0.22389999, "impliedSharesOutstanding": 44478000, "bookValue": -4.213, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -28400000, "trailingEps": -0.58, "forwardEps": 0.83, "enterpriseToRevenue": 0.496, "enterpriseToEbitda": 4.995, "52WeekChange": -0.7784343, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.27, "lastDividendDate": 1568678400, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "TUP", "underlyingSymbol": "TUP", "shortName": "Tupperware Brands Corporation", "longName": "Tupperware Brands Corporation", "firstTradeDateEpochUtc": 831562200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fd8e872c-60fa-3c1b-a9e7-bd649a51ed52", "messageBoardId": "finmb_347586", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.8223, "targetHighPrice": 4.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 110100000, "totalCashPerShare": 2.474, "ebitda": 129600000, "totalDebt": 705400000, "quickRatio": 0.336, "currentRatio": 1.314, "totalRevenue": 1305600000, "revenuePerShare": 28.632, "returnOnAssets": 0.05294, "grossProfits": 836400000, "freeCashflow": -115375000, "operatingCashflow": -49800000, "revenueGrowth": -0.206, "grossMargins": 0.64062, "ebitdaMargins": 0.099259995, "operatingMargins": 0.071609996, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "3 Great Pasture Road", "city": "Danbury", "state": "CT", "zip": "06810", "country": "United States", "phone": "203 825 6000", "website": "https://www.fuelcellenergy.com", "industry": "Electrical Equipment & Parts", "industryKey": "electrical-equipment-parts", "industryDisp": "Electrical Equipment & Parts", "sector": "Industrials", "sectorKey": "industrials", "sectorDisp": "Industrials", "longBusinessSummary": "FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.", "fullTimeEmployees": 513, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jason B. Few", "age": 55, "title": "Pres, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 1152551, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael S. Bishop", "age": 54, "title": "Exec. VP, CFO, Principal Accounting Officer & Treasurer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 718111, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael J. Lisowski", "age": 52, "title": "Exec. VP & COO", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 680612, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joshua  Dolger", "age": 47, "title": "Exec. VP, Gen. Counsel & Corp. Sec.", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": 624603, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Feasel", "age": 51, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 760919, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony J. Leo", "age": 65, "title": "Exec. VP & CTO", "yearBorn": 1957, "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Gelston", "title": "Sr. VP of Fin. & Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betsy  Schaefer", "title": "Chief Marketing & Sustainability Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. -  Parimal", "title": "Chief Strategy & Corp. Devel. Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Farrell", "title": "Sr. VP & Chief HR Officer", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 1, "compensationRisk": 7, "shareHolderRightsRisk": 4, "overallRisk": 3, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.425, "dayLow": 1.32, "dayHigh": 1.44, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.425, "regularMarketDayLow": 1.32, "regularMarketDayHigh": 1.44, "payoutRatio": 0.0, "beta": 3.652609, "forwardPE": -4.568966, "volume": 4682238, "regularMarketVolume": 4682238, "averageVolume": 11990907, "averageVolume10days": 9280710, "averageDailyVolume10Day": 9280710, "bid": 1.36, "ask": 1.37, "bidSize": 3100, "askSize": 27000, "marketCap": 597079424, "fiftyTwoWeekLow": 1.13, "fiftyTwoWeekHigh": 4.36, "priceToSalesTrailing12Months": 4.2608056, "fiftyDayAverage": 1.4726, "twoHundredDayAverage": 2.38915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 365691136, "profitMargins": -0.85398, "floatShares": 449603411, "sharesOutstanding": 450625984, "sharesShort": 81596188, "sharesShortPriorMonth": 68949941, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.18110001, "heldPercentInsiders": 0.00178, "heldPercentInstitutions": 0.50446, "shortRatio": 7.28, "shortPercentOfFloat": 0.1814, "impliedSharesOutstanding": 450625984, "bookValue": 1.573, "priceToBook": 0.8423395, "lastFiscalYearEnd": 1667174400, "nextFiscalYearEnd": 1698710400, "mostRecentQuarter": 1690761600, "netIncomeToCommon": -122871000, "trailingEps": -0.3, "forwardEps": -0.29, "pegRatio": -0.28, "lastSplitFactor": "1:12", "lastSplitDate": 1557360000, "enterpriseToRevenue": 2.61, "enterpriseToEbitda": -3.163, "52WeekChange": -0.5408163, "SandP52WeekChange": 0.2183963, "lastDividendValue": 7.992, "lastDividendDate": 919209600, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "FCEL", "underlyingSymbol": "FCEL", "shortName": "FuelCell Energy, Inc.", "longName": "FuelCell Energy, Inc.", "firstTradeDateEpochUtc": 709479000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "680c2361-cd3c-348e-9850-68f5c797e30c", "messageBoardId": "finmb_332124", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.325, "targetHighPrice": 2.75, "targetLowPrice": 1.0, "targetMeanPrice": 1.96, "targetMedianPrice": 2.0, "recommendationMean": 3.2, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 381110016, "totalCashPerShare": 0.846, "ebitda": -115611000, "totalDebt": 128838000, "quickRatio": 6.953, "currentRatio": 8.724, "totalRevenue": 140132992, "debtToEquity": 16.779, "revenuePerShare": 0.343, "returnOnAssets": -0.09206, "returnOnEquity": -0.15791, "grossProfits": -27775000, "freeCashflow": -159368256, "operatingCashflow": -148500992, "revenueGrowth": -0.408, "grossMargins": -0.1503, "ebitdaMargins": -0.82501, "operatingMargins": -0.99316, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "Riversedge North", "address2": "2529 Virginia Beach Boulevard Suite 200", "city": "Virginia Beach", "state": "VA", "zip": "23452-7650", "country": "United States", "phone": "757 627 9088", "fax": "757 627 9081", "website": "https://www.whlr.us", "industry": "REIT - Retail", "industryKey": "reit-retail", "industryDisp": "REIT - Retail", "sector": "Real Estate", "sectorKey": "real-estate", "sectorDisp": "Real Estate", "longBusinessSummary": "Headquartered in Virginia Beach, Virginia, Wheeler Real Estate Investment Trust, Inc. is a fully integrated, self-managed commercial real estate investment trust (REIT) focused on owning and operating income-producing retail properties with a primary focus on grocery-anchored centers.", "fullTimeEmployees": 47, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael Andrew Franklin", "age": 41, "title": "CEO & Pres", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": 617121, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Crystal  Plum", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": 361737, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Schiefer", "title": "Director of Accounting", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Hedrick", "title": "VP of HR & Admin.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mary  Jensen", "title": "Investor Relations Contact", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Victoria H. Browne", "title": "Marketing Mang.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Angelica A. Beltran", "title": "VP of Project Management & Corp. Sec.", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.89, "open": 1.45, "dayLow": 1.34, "dayHigh": 1.67, "regularMarketPreviousClose": 0.89, "regularMarketOpen": 1.45, "regularMarketDayLow": 1.34, "regularMarketDayHigh": 1.67, "exDividendDate": 1522195200, "payoutRatio": 0.0, "beta": 2.515727, "forwardPE": -0.67061615, "volume": 16087676, "regularMarketVolume": 16087676, "averageVolume": 563546, "averageVolume10days": 731420, "averageDailyVolume10Day": 731420, "bid": 1.55, "ask": 1.57, "bidSize": 1800, "askSize": 1000, "marketCap": 1387912, "fiftyTwoWeekLow": 0.818, "fiftyTwoWeekHigh": 19.9, "priceToSalesTrailing12Months": 0.014392501, "fiftyDayAverage": 3.96102, "twoHundredDayAverage": 9.657355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 677350144, "profitMargins": -0.15444, "floatShares": 552915, "sharesOutstanding": 980857, "sharesShort": 310272, "sharesShortPriorMonth": 5749, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.3163, "shortRatio": 0.25, "shortPercentOfFloat": 0.41419998, "impliedSharesOutstanding": 980857, "bookValue": -73.463, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -23946000, "trailingEps": -17.89, "forwardEps": -2.11, "lastSplitFactor": "1:10", "lastSplitDate": 1692316800, "enterpriseToRevenue": 7.024, "enterpriseToEbitda": 14.342, "52WeekChange": -0.94026846, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.34, "lastDividendDate": 1514332800, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "WHLR", "underlyingSymbol": "WHLR", "shortName": "Wheeler Real Estate Investment ", "longName": "Wheeler Real Estate Investment Trust, Inc.", "firstTradeDateEpochUtc": 1353335400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "acd56172-2ebc-3d5f-9314-3c8f68510dbf", "messageBoardId": "finmb_139437757", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.415, "recommendationKey": "none", "totalCash": 28735000, "totalCashPerShare": 29.294, "ebitda": 47229000, "totalDebt": 485668000, "quickRatio": 2.016, "currentRatio": 3.315, "totalRevenue": 96433000, "debtToEquity": 329.311, "revenuePerShare": 98.447, "returnOnAssets": 0.02728, "returnOnEquity": -0.04595, "grossProfits": 50780000, "freeCashflow": 10725625, "operatingCashflow": 32314000, "revenueGrowth": 0.608, "grossMargins": 0.65732, "ebitdaMargins": 0.48976, "operatingMargins": 0.25812, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "1213 Innsbruck Drive", "city": "Sunnyvale", "state": "CA", "zip": "94089", "country": "United States", "phone": "408 720 9002", "fax": "408 720 9013", "website": "https://silkroadmed.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.", "fullTimeEmployees": 414, "companyOfficers": [{"maxAge": 1, "name": "Ms. Erica J. Rogers", "age": 59, "title": "Pres, CEO & Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 1166381, "exercisedValue": 5125311, "unexercisedValue": 38290096}, {"maxAge": 1, "name": "Mr. Lucas W. Buchanan", "age": 44, "title": "CFO & COO", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": 870552, "exercisedValue": 4568307, "unexercisedValue": 4819502}, {"maxAge": 1, "name": "Mr. Kevin M. Klemz", "age": 61, "title": "EVP, Chief Legal Officer & Sec.", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": 644125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew S. Davis", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 836326, "exercisedValue": 1181313, "unexercisedValue": 7427845}, {"maxAge": 1, "name": "Mr. Richard M. Ruedy", "age": 55, "title": "Exec. VP of Clinical, Regulatory Affairs & Quality Assurance", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 542410, "exercisedValue": 0, "unexercisedValue": 5845605}, {"maxAge": 1, "name": "Ms. Mhairi L. Jones", "age": 51, "title": "Chief Accounting Officer & VP of Fin.", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tammy  Leitsinger", "title": "Compliance Officer & VP of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  McCarthy", "title": "VP of Marketing", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alison  Highlander", "title": "VP of HR", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sumaira  MacDonald M.D., Ph.D.", "title": "Exec. Medical Director", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.99, "open": 7.0, "dayLow": 6.3601, "dayHigh": 7.36, "regularMarketPreviousClose": 13.99, "regularMarketOpen": 7.0, "regularMarketDayLow": 6.3601, "regularMarketDayHigh": 7.36, "payoutRatio": 0.0, "beta": 1.218975, "forwardPE": -5.078947, "volume": 9322859, "regularMarketVolume": 9322859, "averageVolume": 892350, "averageVolume10days": 584400, "averageDailyVolume10Day": 584400, "bid": 6.77, "ask": 6.85, "bidSize": 2900, "askSize": 1200, "marketCap": 262316912, "fiftyTwoWeekLow": 6.3601, "fiftyTwoWeekHigh": 58.04, "priceToSalesTrailing12Months": 1.6105511, "fiftyDayAverage": 18.398, "twoHundredDayAverage": 35.1646, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 443557856, "profitMargins": -0.32465, "floatShares": 38029537, "sharesOutstanding": 38833000, "sharesShort": 1819367, "sharesShortPriorMonth": 1483903, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0469, "heldPercentInsiders": 0.02348, "heldPercentInstitutions": 1.15786, "shortRatio": 3.11, "shortPercentOfFloat": 0.0477, "impliedSharesOutstanding": 38833000, "bookValue": 4.007, "priceToBook": 1.6857998, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -52877000, "trailingEps": -1.37, "forwardEps": -1.33, "pegRatio": -0.59, "enterpriseToRevenue": 2.723, "enterpriseToEbitda": -8.784, "52WeekChange": -0.6718273, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SILK", "underlyingSymbol": "SILK", "shortName": "Silk Road Medical, Inc.", "longName": "Silk Road Medical, Inc", "firstTradeDateEpochUtc": 1554384600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8c3f6c14-9d16-3565-a790-298e26fb81f1", "messageBoardId": "finmb_34242723", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.755, "targetHighPrice": 54.0, "targetLowPrice": 11.0, "targetMeanPrice": 32.11, "targetMedianPrice": 35.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 188360992, "totalCashPerShare": 4.851, "ebitda": -50494000, "totalDebt": 84762000, "quickRatio": 8.71, "currentRatio": 9.69, "totalRevenue": 162874000, "debtToEquity": 54.508, "revenuePerShare": 4.337, "returnOnAssets": -0.15573, "returnOnEquity": -0.49066, "grossProfits": 100762000, "freeCashflow": -7437750, "operatingCashflow": -24213000, "revenueGrowth": 0.366, "grossMargins": 0.71869004, "ebitdaMargins": -0.31002, "operatingMargins": -0.32591, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "1545 Route 206 South", "address2": "Suite 302", "city": "Bedminster", "state": "NJ", "zip": "07921", "country": "United States", "phone": "908 484 8805", "website": "https://www.matinasbiopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 fatty acid-based composition intended for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. Matinas BioPharma Holdings, Inc. has a research collaboration with the National Institute of Allergy and Infectious Diseases for the development of Gilead's antiviral remdesivir; and a feasibility collaboration with Genentech, Inc. for the development of oral formulations. Matinas BioPharma Holdings, Inc. was incorporated in 2013 and is based in Bedminster, New Jersey.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jerome D. Jabbour J.D.", "age": 48, "title": "Co-Founder, CEO, Pres & Director", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 881500, "exercisedValue": 0, "unexercisedValue": 40250}, {"maxAge": 1, "name": "Dr. Theresa  Matkovits Ph.D.", "age": 55, "title": "Chief Devel. Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 601000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James J. Ferguson FACC, M.D.", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": 619920, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keith A. Kucinski CPA, M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2019, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hui  Liu M.B.A., Ph.D.", "age": 54, "title": "Chief Technology Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frank  Calamusa", "title": "Exec. Director and Head of Manufacturing & Supply Chain", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas J. Hoover M.B.A.", "age": 52, "title": "Chief Bus. Officer", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.155, "open": 0.2701, "dayLow": 0.2535, "dayHigh": 0.355, "regularMarketPreviousClose": 0.155, "regularMarketOpen": 0.2701, "regularMarketDayLow": 0.2535, "regularMarketDayHigh": 0.355, "payoutRatio": 0.0, "beta": 2.08123, "forwardPE": -2.0592308, "volume": 86510434, "regularMarketVolume": 86510434, "averageVolume": 1156826, "averageVolume10days": 3391680, "averageDailyVolume10Day": 3391680, "bid": 0.3138, "ask": 0.3139, "bidSize": 1100, "askSize": 1000, "marketCap": 67612984, "fiftyTwoWeekLow": 0.11, "fiftyTwoWeekHigh": 0.89, "priceToSalesTrailing12Months": 20.991302, "fiftyDayAverage": 0.1828, "twoHundredDayAverage": 0.398405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 16103324, "profitMargins": 0.0, "floatShares": 210516290, "sharesOutstanding": 217264992, "sharesShort": 278532, "sharesShortPriorMonth": 1146481, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0013, "heldPercentInsiders": 0.02915, "heldPercentInstitutions": 0.12169, "shortRatio": 0.44, "shortPercentOfFloat": 0.0013, "impliedSharesOutstanding": 252570000, "bookValue": 0.128, "priceToBook": 2.091406, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -20669000, "trailingEps": -0.12, "forwardEps": -0.13, "enterpriseToRevenue": 4.999, "enterpriseToEbitda": -0.722, "52WeekChange": -0.7753623, "SandP52WeekChange": 0.2183963, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "MTNB", "underlyingSymbol": "MTNB", "shortName": "Matinas Biopharma Holdings, Inc", "longName": "Matinas BioPharma Holdings, Inc.", "firstTradeDateEpochUtc": 1405949400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "61dd6a0e-9ad0-3bcd-b1dc-4dae373fc621", "messageBoardId": "finmb_243651290", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2677, "targetHighPrice": 3.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.25, "targetMedianPrice": 2.25, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 22513000, "totalCashPerShare": 0.104, "ebitda": -22303000, "totalDebt": 3854000, "quickRatio": 8.696, "currentRatio": 9.27, "totalRevenue": 3221000, "debtToEquity": 13.836, "revenuePerShare": 0.015, "returnOnAssets": -0.32806998, "returnOnEquity": -0.58467, "grossProfits": -13490000, "freeCashflow": -9229634, "operatingCashflow": -15549000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.04346, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "108 Wilmot Road", "city": "Deerfield", "state": "IL", "zip": "60015", "country": "United States", "phone": "847 315 3700", "website": "https://www.walgreensbootsalliance.com", "industry": "Pharmaceutical Retailers", "industryKey": "pharmaceutical-retailers", "industryDisp": "Pharmaceutical Retailers", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.", "fullTimeEmployees": 325000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stefano  Pessina", "age": 81, "title": "Executive Chairman of the Board", "yearBorn": 1941, "fiscalYear": 2022, "totalPay": 111252, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ginger L. Graham", "age": 66, "title": "Interim CEO & Director", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": 100000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ornella  Barra", "age": 69, "title": "Chief Operating Officer of International", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 3111887, "exercisedValue": 0, "unexercisedValue": 47291}, {"maxAge": 1, "name": "Mr. Manmohan  Mahajan", "age": 43, "title": "Interim Global CFO & Principal Financial Officer", "yearBorn": 1979, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Todd  Heckman", "age": 49, "title": "Interim Global Controller & Principal Accounting Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald  Gradwell", "age": 54, "title": "Senior Vice President of Investor Relations", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Danielle Carim Gray", "age": 44, "title": "Executive VP & Global Chief Legal Officer", "yearBorn": 1978, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth A. Leonard", "title": "Senior VP & Chief Communications Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Holly  May", "age": 39, "title": "Executive VP & Global Chief Human Resources Officer", "yearBorn": 1983, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles V. Greener", "age": 63, "title": "Senior VP & Global Chief Public Affairs Officer", "yearBorn": 1959, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 2, "overallRisk": 9, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 22.38, "open": 23.21, "dayLow": 22.66, "dayHigh": 23.94, "regularMarketPreviousClose": 22.38, "regularMarketOpen": 23.21, "regularMarketDayLow": 22.66, "regularMarketDayHigh": 23.94, "dividendRate": 1.92, "dividendYield": 0.0858, "exDividendDate": 1692316800, "payoutRatio": 0.38169998, "fiveYearAvgDividendYield": 4.27, "beta": 0.794, "forwardPE": 6.08311, "volume": 4997652, "regularMarketVolume": 4997652, "averageVolume": 10574728, "averageVolume10days": 11359400, "averageDailyVolume10Day": 11359400, "bid": 22.82, "ask": 22.82, "bidSize": 1000, "askSize": 1200, "marketCap": 19587391488, "fiftyTwoWeekLow": 20.58, "fiftyTwoWeekHigh": 42.29, "priceToSalesTrailing12Months": 0.14391066, "fiftyDayAverage": 24.6576, "twoHundredDayAverage": 31.39355, "trailingAnnualDividendRate": 1.92, "trailingAnnualDividendYield": 0.08579089, "currency": "USD", "enterpriseValue": 64226791424, "profitMargins": -0.024360001, "floatShares": 714987633, "sharesOutstanding": 863260992, "sharesShort": 49743702, "sharesShortPriorMonth": 42912487, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.057600003, "heldPercentInsiders": 0.1719, "heldPercentInstitutions": 0.61095, "shortRatio": 3.43, "shortPercentOfFloat": 0.0695, "impliedSharesOutstanding": 863260992, "bookValue": 24.399, "priceToBook": 0.92995614, "lastFiscalYearEnd": 1661904000, "nextFiscalYearEnd": 1693440000, "mostRecentQuarter": 1685491200, "earningsQuarterlyGrowth": -0.592, "netIncomeToCommon": -3315000064, "trailingEps": -3.84, "forwardEps": 3.73, "pegRatio": -1.51, "lastSplitFactor": "2:1", "lastSplitDate": 919123200, "enterpriseToRevenue": 0.472, "enterpriseToEbitda": 22.488, "52WeekChange": -0.29931122, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.48, "lastDividendDate": 1692316800, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "WBA", "underlyingSymbol": "WBA", "shortName": "Walgreens Boots Alliance, Inc.", "longName": "Walgreens Boots Alliance, Inc.", "firstTradeDateEpochUtc": 322151400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "888fa4a2-1f3d-3718-83dd-229207680ca9", "messageBoardId": "finmb_93624", "gmtOffSetMilliseconds": -14400000, "currentPrice": 22.69, "targetHighPrice": 45.0, "targetLowPrice": 22.0, "targetMeanPrice": 29.15, "targetMedianPrice": 27.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 13, "totalCash": 970000000, "totalCashPerShare": 1.124, "ebitda": 2856000000, "totalDebt": 37420998656, "quickRatio": 0.26, "currentRatio": 0.632, "totalRevenue": 136107999232, "debtToEquity": 126.769, "revenuePerShare": 157.637, "returnOnAssets": 0.0066799996, "returnOnEquity": -0.12595001, "grossProfits": 28266000000, "freeCashflow": 1337750016, "operatingCashflow": 1304999936, "earningsGrowth": -0.586, "revenueGrowth": 0.086, "grossMargins": 0.19843, "ebitdaMargins": 0.02098, "operatingMargins": -0.0069199996, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "Assar Gabrielssons VAeG 9", "city": "Gothenburg", "zip": "40531", "country": "Sweden", "website": "https://www.polestar.com", "industry": "Auto Manufacturers", "industryKey": "auto-manufacturers", "industryDisp": "Auto Manufacturers", "sector": "Consumer Cyclical", "sectorKey": "consumer-cyclical", "sectorDisp": "Consumer Cyclical", "longBusinessSummary": "Polestar Automotive Holding UK PLC manufactures and sells premium electric vehicles. The company was founded in 2017 and is headquartered in Gothenburg, Sweden.", "fullTimeEmployees": 2377, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Ingenlath", "age": 58, "title": "CEO & Director", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Johan L. Malmqvist", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Roger  Molin", "title": "Head of Group Financial Accounting & Control", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bojana  Flint", "title": "Head of Investor Relations?", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jorg  Brandscheid", "title": "CTO - R&D", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mikael  Alkmark", "title": "Deputy Chief Financial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonas  Engstr\u00f6m", "title": "Head of Operations", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 2.9, "open": 2.67, "dayLow": 2.62, "dayHigh": 2.87, "regularMarketPreviousClose": 2.9, "regularMarketOpen": 2.67, "regularMarketDayLow": 2.62, "regularMarketDayHigh": 2.87, "payoutRatio": 0.0, "forwardPE": -6.366667, "volume": 1237733, "regularMarketVolume": 1237733, "averageVolume": 3705048, "averageVolume10days": 3564170, "averageDailyVolume10Day": 3564170, "bid": 2.79, "ask": 2.8, "bidSize": 2900, "askSize": 3200, "marketCap": 6045579776, "fiftyTwoWeekLow": 2.16, "fiftyTwoWeekHigh": 8.25, "priceToSalesTrailing12Months": 2.2797472, "fiftyDayAverage": 3.2614, "twoHundredDayAverage": 4.0909, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 7125052416, "profitMargins": -0.10411, "sharesOutstanding": 2110150016, "sharesShort": 16365117, "sharesShortPriorMonth": 9893452, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0078, "heldPercentInsiders": 0.47313, "heldPercentInstitutions": 0.039920002, "shortRatio": 4.06, "impliedSharesOutstanding": 2110150016, "bookValue": -0.223, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -276089984, "trailingEps": -0.12, "forwardEps": -0.45, "pegRatio": 0.51, "enterpriseToRevenue": 2.687, "enterpriseToEbitda": -9.188, "52WeekChange": -0.43469787, "SandP52WeekChange": 0.2183963, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "PSNY", "underlyingSymbol": "PSNY", "shortName": "Polestar Automotive Holding UK ", "longName": "Polestar Automotive Holding UK PLC", "firstTradeDateEpochUtc": 1621344600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a6848539-21b7-3360-a0d0-ee1c9a722fe5", "messageBoardId": "finmb_248971669", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.865, "targetHighPrice": 9.0, "targetLowPrice": 1.6, "targetMeanPrice": 5.09, "targetMedianPrice": 5.0, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 1057411968, "totalCashPerShare": 0.501, "ebitda": -775505024, "totalDebt": 2506167040, "quickRatio": 0.335, "currentRatio": 0.591, "totalRevenue": 2651864064, "revenuePerShare": 1.257, "returnOnAssets": -0.13828, "grossProfits": 119443000, "freeCashflow": -1887191424, "operatingCashflow": -1342237056, "revenueGrowth": 0.163, "grossMargins": 0.03154, "ebitdaMargins": -0.29244, "operatingMargins": -0.32854, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "225 Bush Street", "address2": "Suite 1400", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 580 6900", "website": "https://www.sunrun.com", "industry": "Solar", "industryKey": "solar", "industryDisp": "Solar", "sector": "Technology", "sectorKey": "technology", "sectorDisp": "Technology", "longBusinessSummary": "Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar energy systems and products, such as panels and racking; and solar leads generated to customers. In addition, the company offers battery storage along with solar energy systems; and sells services to commercial developers through multi-family and new homes. Its primary customers are residential homeowners. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media, digital media, canvassing, field marketing, and referral channels, as well as its partner network. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California.", "fullTimeEmployees": 12408, "companyOfficers": [{"maxAge": 1, "name": "Mr. Edward Harris Fenster", "age": 45, "title": "Co-Founder & Executive Co-Chair of the Board", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": 1071788, "exercisedValue": 1392146, "unexercisedValue": 28049964}, {"maxAge": 1, "name": "Ms. Lynn Michelle Jurich", "age": 42, "title": "Co-Founder, Executive Co-Chair of the Board", "yearBorn": 1980, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Grace Powell", "age": 62, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 2596355, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Danny  Abajian", "age": 37, "title": "CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1985, "fiscalYear": 2022, "totalPay": 999991, "exercisedValue": 186851, "unexercisedValue": 1018083}, {"maxAge": 1, "name": "Ms. Jeanna  Steele", "age": 47, "title": "Chief Legal & People Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": 786202, "exercisedValue": 0, "unexercisedValue": 542070}, {"maxAge": 1, "name": "Mr. Paul S. Dickson", "age": 37, "title": "Chief Revenue Officer", "yearBorn": 1985, "fiscalYear": 2022, "totalPay": 1442219, "exercisedValue": 0, "unexercisedValue": 635570}, {"maxAge": 1, "name": "Mr. Patrick  Jobin", "title": "Senior VP of Finance & Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Newbold", "title": "Director of Communications", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chance  Allred", "title": "Chief Experience Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chris  McClellan", "title": "Chief Field Operations Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 4, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 11.93, "open": 12.11, "dayLow": 11.88, "dayHigh": 12.4, "regularMarketPreviousClose": 11.93, "regularMarketOpen": 12.11, "regularMarketDayLow": 11.88, "regularMarketDayHigh": 12.4, "payoutRatio": 0.0, "beta": 2.409, "trailingPE": 24.916668, "forwardPE": -13.0, "volume": 3239656, "regularMarketVolume": 3239656, "averageVolume": 10051546, "averageVolume10days": 14006350, "averageDailyVolume10Day": 14006350, "bid": 12.03, "ask": 12.04, "bidSize": 1000, "askSize": 1100, "marketCap": 2597508864, "fiftyTwoWeekLow": 9.6, "fiftyTwoWeekHigh": 33.33, "priceToSalesTrailing12Months": 1.0728631, "fiftyDayAverage": 14.4157, "twoHundredDayAverage": 19.28515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 13535687680, "profitMargins": 0.03662, "floatShares": 211875396, "sharesOutstanding": 217183008, "sharesShort": 48507855, "sharesShortPriorMonth": 38807400, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.2234, "heldPercentInsiders": 0.026659999, "heldPercentInstitutions": 1.00871, "shortRatio": 5.64, "shortPercentOfFloat": 0.26770002, "impliedSharesOutstanding": 217183008, "bookValue": 30.397, "priceToBook": 0.3934599, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": 88667000, "trailingEps": 0.48, "forwardEps": -0.92, "pegRatio": 1.43, "enterpriseToRevenue": 5.591, "enterpriseToEbitda": -58.175, "52WeekChange": -0.48754293, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "RUN", "underlyingSymbol": "RUN", "shortName": "Sunrun Inc.", "longName": "Sunrun Inc.", "firstTradeDateEpochUtc": 1438781400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "855520d2-a5b0-31a6-8b93-9e7e30889e2a", "messageBoardId": "finmb_44576381", "gmtOffSetMilliseconds": -14400000, "currentPrice": 11.96, "targetHighPrice": 60.0, "targetLowPrice": 12.0, "targetMeanPrice": 31.95, "targetMedianPrice": 27.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 23, "totalCash": 669094016, "totalCashPerShare": 3.081, "ebitda": -232671008, "totalDebt": 10016120832, "quickRatio": 0.622, "currentRatio": 1.465, "totalRevenue": 2421100032, "debtToEquity": 122.221, "revenuePerShare": 11.33, "returnOnAssets": -0.02352, "returnOnEquity": -0.14491999, "grossProfits": 298712000, "freeCashflow": -2499941376, "operatingCashflow": -1036025024, "revenueGrowth": 0.01, "grossMargins": 0.10281, "ebitdaMargins": -0.096099995, "operatingMargins": -0.34894, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "One Baxter Parkway", "city": "Deerfield", "state": "IL", "zip": "60015", "country": "United States", "phone": "224 948 2000", "website": "https://www.baxter.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.", "fullTimeEmployees": 60000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jose E. Almeida", "age": 60, "title": "Chairman of the Board, President & CEO", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 2097448, "exercisedValue": 0, "unexercisedValue": 9985352}, {"maxAge": 1, "name": "Mr. David S. Rosenbloom", "age": 62, "title": "Executive VP & General Counsel", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 776510, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian C. Stevens", "age": 47, "title": "Senior VP, Interim CFO, Chief Accounting Officer & Controller", "yearBorn": 1975, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talvis P. Love", "age": 54, "title": "Senior VP & Chief Information Officer", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tobi  Karchmer M.D., M.S.", "title": "Senior VP and Chief Medical & Scientific Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Clare  Trachtman", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacey  Eisen", "title": "Senior Vice President of Global Communications", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jeanne K. Mason Ph.D.", "age": 66, "title": "?Executive VP & Chief Human Resources Officer", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": 1994616, "exercisedValue": 0, "unexercisedValue": 1633219}, {"maxAge": 1, "name": "Mr. James W. Borzi", "age": 59, "title": "Executive VP & Chief Supply Chain Officer", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather  Knight", "title": "Executive VP & Group President of Medical Products and Therapies", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 1, "overallRisk": 7, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 37.32, "open": 35.8, "dayLow": 33.94, "dayHigh": 36.275, "regularMarketPreviousClose": 37.32, "regularMarketOpen": 35.8, "regularMarketDayLow": 33.94, "regularMarketDayHigh": 36.275, "dividendRate": 1.16, "dividendYield": 0.0311, "exDividendDate": 1693440000, "payoutRatio": 0.565, "fiveYearAvgDividendYield": 1.49, "beta": 0.561, "forwardPE": 11.053571, "volume": 4049943, "regularMarketVolume": 4049943, "averageVolume": 4455131, "averageVolume10days": 4867320, "averageDailyVolume10Day": 4867320, "bid": 34.05, "ask": 34.08, "bidSize": 900, "askSize": 1400, "marketCap": 17240557568, "fiftyTwoWeekLow": 33.94, "fiftyTwoWeekHigh": 58.12, "priceToSalesTrailing12Months": 1.1356668, "fiftyDayAverage": 40.1368, "twoHundredDayAverage": 42.87175, "trailingAnnualDividendRate": 1.16, "trailingAnnualDividendYield": 0.03108253, "currency": "USD", "enterpriseValue": 34160027648, "profitMargins": -0.18792999, "floatShares": 504698243, "sharesOutstanding": 506404992, "sharesShort": 8908639, "sharesShortPriorMonth": 7172420, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0176, "heldPercentInsiders": 0.0027200002, "heldPercentInstitutions": 0.89075994, "shortRatio": 2.37, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 506404992, "bookValue": 10.998, "priceToBook": 3.0955627, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -2816999936, "trailingEps": -5.59, "forwardEps": 3.08, "pegRatio": 3.14, "lastSplitFactor": "1841:1000", "lastSplitDate": 1435708800, "enterpriseToRevenue": 2.25, "enterpriseToEbitda": 11.105, "52WeekChange": -0.32145452, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.29, "lastDividendDate": 1693440000, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "BAX", "underlyingSymbol": "BAX", "shortName": "Baxter International Inc.", "longName": "Baxter International Inc.", "firstTradeDateEpochUtc": 373041000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6ab3de01-de88-3bf0-be41-5437c59fc509", "messageBoardId": "finmb_254571", "gmtOffSetMilliseconds": -14400000, "currentPrice": 34.045, "targetHighPrice": 56.0, "targetLowPrice": 41.0, "targetMeanPrice": 49.83, "targetMedianPrice": 50.5, "recommendationMean": 2.6, "recommendationKey": "hold", "numberOfAnalystOpinions": 12, "totalCash": 1722000000, "totalCashPerShare": 3.4, "ebitda": 3076000000, "totalDebt": 16920999936, "quickRatio": 0.74, "currentRatio": 1.423, "totalRevenue": 15180999680, "debtToEquity": 300.497, "revenuePerShare": 30.032, "returnOnAssets": 0.03701, "returnOnEquity": -0.38627, "grossProfits": 6031000000, "freeCashflow": 1140875008, "operatingCashflow": 1559000064, "revenueGrowth": 0.031, "grossMargins": 0.38779, "ebitdaMargins": 0.20261998, "operatingMargins": 0.092530005, "financialCurrency": "USD", "trailingPegRatio": 2.6084}, {"address1": "980 Rock Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 503 8000", "fax": "408 503 8008", "website": "https://www.supermicro.com", "industry": "Computer Hardware", "industryKey": "computer-hardware", "industryDisp": "Computer Hardware", "sector": "Technology", "sectorKey": "technology", "sectorDisp": "Technology", "longBusinessSummary": "Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.", "fullTimeEmployees": 5126, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles  Liang", "age": 64, "title": "Founder, Chairman, Pres & CEO", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1, "exercisedValue": 13472113, "unexercisedValue": 187163520}, {"maxAge": 1, "name": "Mr. David E. Weigand", "age": 63, "title": "Sr. VP, CFO, Company Sec. & Chief Compliance Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 837846, "exercisedValue": 0, "unexercisedValue": 9265669}, {"maxAge": 1, "name": "Mr. George  Kao", "age": 60, "title": "Sr. VP of Operations", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 409175, "exercisedValue": 0, "unexercisedValue": 6968827}, {"maxAge": 1, "name": "Mr. Don W. Clegg", "age": 62, "title": "Sr. VP of Worldwide Sales", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 696280, "exercisedValue": 1656171, "unexercisedValue": 6409807}, {"maxAge": 1, "name": "Ms. Chiu-Chu  Liu Liang", "age": 60, "title": "Co-Founder, Sr. VP & Director", "yearBorn": 1962, "fiscalYear": 2018, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Chang", "title": "Gen. Counsel", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  McNerney", "title": "VP of Marketing & Network Security", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Wang", "title": "Pres of East Coast & SVP of Strategy and Corp. Devel.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shin-Chun  Hsu", "age": 73, "title": "Sr. Chief Exec. of Strategic Bus.", "yearBorn": 1949, "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vik  Malyala", "title": "Sr. VP, MD & Pres of the EMEA Division", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 8, "compensationRisk": 4, "shareHolderRightsRisk": 5, "overallRisk": 4, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 310.31, "open": 311.1, "dayLow": 304.58, "dayHigh": 315.97, "regularMarketPreviousClose": 310.31, "regularMarketOpen": 311.1, "regularMarketDayLow": 304.58, "regularMarketDayHigh": 315.97, "payoutRatio": 0.0, "beta": 1.130314, "trailingPE": 25.362225, "forwardPE": 15.84977, "volume": 1198910, "regularMarketVolume": 1198910, "averageVolume": 3314396, "averageVolume10days": 3248600, "averageDailyVolume10Day": 3248600, "bid": 309.0, "ask": 309.91, "bidSize": 900, "askSize": 900, "marketCap": 16410351616, "fiftyTwoWeekLow": 50.28, "fiftyTwoWeekHigh": 357.0, "priceToSalesTrailing12Months": 2.303698, "fiftyDayAverage": 273.8694, "twoHundredDayAverage": 180.28336, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 16286312448, "profitMargins": 0.08984, "floatShares": 46025000, "sharesOutstanding": 52905900, "sharesShort": 4549913, "sharesShortPriorMonth": 3501474, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.086, "heldPercentInsiders": 0.13083, "heldPercentInstitutions": 0.81251, "shortRatio": 1.54, "shortPercentOfFloat": 0.1121, "impliedSharesOutstanding": 52905900, "bookValue": 37.277, "priceToBook": 8.320949, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.375, "netIncomeToCommon": 639998016, "trailingEps": 12.23, "forwardEps": 19.57, "pegRatio": 1.73, "enterpriseToRevenue": 2.286, "enterpriseToEbitda": 20.459, "52WeekChange": 4.9196873, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SMCI", "underlyingSymbol": "SMCI", "shortName": "Super Micro Computer, Inc.", "longName": "Super Micro Computer, Inc.", "firstTradeDateEpochUtc": 1175175000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "288ea95a-d6fb-3cc8-896b-d15447eb97f4", "messageBoardId": "finmb_6479558", "gmtOffSetMilliseconds": -14400000, "currentPrice": 310.18, "targetHighPrice": 400.0, "targetLowPrice": 250.0, "targetMeanPrice": 347.0, "targetMedianPrice": 355.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 440559008, "totalCashPerShare": 8.327, "ebitda": 796046016, "totalDebt": 309462016, "quickRatio": 1.176, "currentRatio": 2.313, "totalRevenue": 7123482112, "debtToEquity": 15.691, "revenuePerShare": 134.596, "returnOnAssets": 0.13829, "returnOnEquity": 0.37669998, "grossProfits": 1283012000, "freeCashflow": 497346880, "operatingCashflow": 663580032, "earningsGrowth": 0.316, "revenueGrowth": 0.336, "grossMargins": 0.18011, "ebitdaMargins": 0.11175, "operatingMargins": 0.106850006, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "47281 Bayside Parkway", "city": "Fremont", "state": "CA", "zip": "94538", "country": "United States", "phone": "707-774-7000", "website": "https://www.enphase.com", "industry": "Solar", "industryKey": "solar", "industryDisp": "Solar", "sector": "Technology", "sectorKey": "technology", "sectorDisp": "Technology", "longBusinessSummary": "Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level, and combines with its proprietary networking and software technologies to provide energy monitoring and control services. It also provides microinverter units and related accessories, an IQ gateway; IQ batteries; the cloud-based Enlighten monitoring service; storage solutions; and electric vehicle charging solutions; and design, proposal, permitting, and lead generation services. The company sells its solutions to solar distributors; and directly to large installers, original equipment manufacturers, strategic partners, and homeowners, as well as through its legacy product upgrade program or online store. Enphase Energy, Inc. was incorporated in 2006 and is headquartered in Fremont, California.", "fullTimeEmployees": 2821, "companyOfficers": [{"maxAge": 1, "name": "Mr. Badrinarayanan  Kothandaraman", "age": 49, "title": "Pres, CEO & Director", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 1016777, "exercisedValue": 154239104, "unexercisedValue": 246441808}, {"maxAge": 1, "name": "Ms. Mandy  Yang", "age": 46, "title": "VP & CFO", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": 745341, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  McNeil", "age": 60, "title": "Chief Advisor", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 808351, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Fornage", "age": 58, "title": "Co-Founder", "yearBorn": 1964, "fiscalYear": 2010, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raghuveer R. Belur", "age": 54, "title": "Co-Founder & Chief Products Officer", "yearBorn": 1968, "fiscalYear": 2010, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ron  Swenson", "title": "VP of Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hans Van Antwerpen", "title": "VP & CTO", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Karen  Sagot", "title": "Head Of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisan  Hung", "age": 53, "title": "VP, Gen. Counsel & Corp. Sec.", "yearBorn": 1969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sunil  Thamaran", "title": "VP of HR & MD of India", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 125.75, "open": 127.36, "dayLow": 127.02, "dayHigh": 131.91, "regularMarketPreviousClose": 125.75, "regularMarketOpen": 127.36, "regularMarketDayLow": 127.02, "regularMarketDayHigh": 131.91, "payoutRatio": 0.0, "beta": 1.512616, "trailingPE": 30.383055, "forwardPE": 19.798601, "volume": 1241694, "regularMarketVolume": 1241694, "averageVolume": 3803545, "averageVolume10days": 3706740, "averageDailyVolume10Day": 3706740, "bid": 127.97, "ask": 128.04, "bidSize": 1100, "askSize": 1800, "marketCap": 17358673920, "fiftyTwoWeekLow": 111.44, "fiftyTwoWeekHigh": 339.92, "priceToSalesTrailing12Months": 6.207288, "fiftyDayAverage": 126.639, "twoHundredDayAverage": 179.8744, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 16613841920, "profitMargins": 0.20477, "floatShares": 131033980, "sharesOutstanding": 136355008, "sharesShort": 11595172, "sharesShortPriorMonth": 10690173, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.085, "heldPercentInsiders": 0.02548, "heldPercentInstitutions": 0.79403, "shortRatio": 3.59, "shortPercentOfFloat": 0.11270001, "impliedSharesOutstanding": 136355008, "bookValue": 7.173, "priceToBook": 17.747805, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 1.042, "netIncomeToCommon": 572628992, "trailingEps": 4.19, "forwardEps": 6.43, "pegRatio": 0.91, "enterpriseToRevenue": 5.941, "enterpriseToEbitda": 24.009, "52WeekChange": -0.49320918, "SandP52WeekChange": 0.2183963, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ENPH", "underlyingSymbol": "ENPH", "shortName": "Enphase Energy, Inc.", "longName": "Enphase Energy, Inc.", "firstTradeDateEpochUtc": 1333114200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5e94a4bb-e413-3d84-9d5f-c49df8281b53", "messageBoardId": "finmb_40485464", "gmtOffSetMilliseconds": -14400000, "currentPrice": 127.305, "targetHighPrice": 335.95, "targetLowPrice": 114.0, "targetMeanPrice": 189.28, "targetMedianPrice": 180.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 32, "totalCash": 1800492032, "totalCashPerShare": 13.245, "ebitda": 691993024, "totalDebt": 1320580992, "quickRatio": 3.172, "currentRatio": 3.444, "totalRevenue": 2796498944, "debtToEquity": 135.78, "revenuePerShare": 20.519, "returnOnAssets": 0.13473, "returnOnEquity": 0.80449, "grossProfits": 974595000, "freeCashflow": 587812608, "operatingCashflow": 957198976, "earningsGrowth": 1.027, "revenueGrowth": 0.341, "grossMargins": 0.43924, "ebitdaMargins": 0.24745001, "operatingMargins": 0.22750999, "financialCurrency": "USD", "trailingPegRatio": 1.2734}, {"address1": "112 NE 41st Street", "address2": "Suite 106", "city": "Miami Beach", "state": "FL", "zip": "33137", "country": "United States", "phone": "212 739 7700", "fax": "212 655 3681", "website": "https://www.gauchoholdings.com", "industry": "Real Estate - Diversified", "industryKey": "real-estate-diversified", "industryDisp": "Real Estate - Diversified", "sector": "Real Estate", "sectorKey": "real-estate", "sectorDisp": "Real Estate", "longBusinessSummary": "Gaucho Group Holdings, Inc., through its subsidiaries, invests in, develops, and operates real estate projects in Argentina. The company owns and operates boutique hotel, hospitality, and luxury vineyard property market; a resort and winery property, 9-hole golf course, tennis courts, dining, and a hotel. It also manufactures and sells leather goods, ready-to-wear, home d\u00e9cor, fashion products, and accessories through e-commerce platforms. The company was formerly known as Algodon Group, Inc. and changed its name to Gaucho Group Holdings, Inc. in March 2019. Gaucho Group Holdings, Inc. was incorporated in 1999 and is based in Miami, Florida.", "fullTimeEmployees": 85, "companyOfficers": [{"maxAge": 1, "name": "Mr. Scott Lee Mathis", "age": 60, "title": "Founder, Pres, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 767441, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria I. Echevarria", "age": 43, "title": "CFO, COO, Compliance Officer, Treasurer & Sec.", "yearBorn": 1979, "fiscalYear": 2022, "totalPay": 322000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Stear", "title": "Ambassador & Director of Marketing", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keith Todd Fasano", "age": 53, "title": "Ambassador & Sr. MD", "yearBorn": 1969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory  Gassoso", "title": "Ambassador & Sr. MD of Real Estate Devel.", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian J. Stern", "title": "Ambassador & Sr. MD of Venture Capital", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.89, "open": 1.09, "dayLow": 1.06, "dayHigh": 1.35, "regularMarketPreviousClose": 0.89, "regularMarketOpen": 1.09, "regularMarketDayLow": 1.06, "regularMarketDayHigh": 1.35, "payoutRatio": 0.0, "beta": 0.210162, "volume": 8050532, "regularMarketVolume": 8050532, "averageVolume": 831066, "averageVolume10days": 5187680, "averageDailyVolume10Day": 5187680, "bid": 1.15, "ask": 1.16, "bidSize": 1300, "askSize": 3200, "marketCap": 1406332, "fiftyTwoWeekLow": 0.861, "fiftyTwoWeekHigh": 57.9, "priceToSalesTrailing12Months": 0.71332157, "fiftyDayAverage": 3.3448, "twoHundredDayAverage": 8.0858, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 5081744, "profitMargins": 0.0, "floatShares": 688029, "sharesOutstanding": 1059300, "sharesShort": 4211, "sharesShortPriorMonth": 2253, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0049, "shortRatio": 0.57, "shortPercentOfFloat": 0.0052, "impliedSharesOutstanding": 1214030, "bookValue": 12.285, "priceToBook": 0.09429386, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -21937672, "trailingEps": -53.14, "lastSplitFactor": "1:10", "lastSplitDate": 1695600000, "enterpriseToRevenue": 2.578, "enterpriseToEbitda": -0.624, "52WeekChange": -0.96628785, "SandP52WeekChange": 0.2183963, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "VINO", "underlyingSymbol": "VINO", "shortName": "Gaucho Group Holdings, Inc.", "longName": "Gaucho Group Holdings, Inc.", "firstTradeDateEpochUtc": 1611066600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f4845531-e6da-3cbd-a287-b2c62b8f9481", "messageBoardId": "finmb_163024919", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.1584, "recommendationKey": "none", "totalCash": 810139, "totalCashPerShare": 1.093, "ebitda": -8143356, "totalDebt": 5232504, "quickRatio": 0.171, "currentRatio": 0.59, "totalRevenue": 1971526, "debtToEquity": 62.551, "revenuePerShare": 4.931, "returnOnAssets": -0.24024001, "returnOnEquity": -1.89784, "grossProfits": 167755, "freeCashflow": -3302126, "operatingCashflow": -6978774, "revenueGrowth": 0.754, "grossMargins": 0.15482001, "ebitdaMargins": 0.0, "operatingMargins": -4.31138, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "257 Simarano Drive", "address2": "Suite 101", "city": "Marlborough", "state": "MA", "zip": "01752", "country": "United States", "phone": "508 767 3861", "website": "https://www.phiopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. Bitterman", "age": 71, "title": "Pres, CEO & Chairman", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": 141462, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caitlin  Kontulis", "age": 36, "title": "VP of Fin. & Admin. and Sec.", "yearBorn": 1986, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jim  Cardia", "title": "VP of Scientific Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda M. Mahoney", "title": "Sr. VP of Devel.", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.36, "open": 1.57, "dayLow": 1.56, "dayHigh": 2.03, "regularMarketPreviousClose": 1.36, "regularMarketOpen": 1.57, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 2.03, "payoutRatio": 0.0, "beta": 1.318008, "forwardPE": -0.6868132, "volume": 9980787, "regularMarketVolume": 9980787, "averageVolume": 24498, "averageVolume10days": 19270, "averageDailyVolume10Day": 19270, "bid": 1.91, "ask": 1.99, "bidSize": 2900, "askSize": 1400, "marketCap": 4165987, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 12.27, "fiftyDayAverage": 1.9898, "twoHundredDayAverage": 3.932905, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": -8147948, "profitMargins": 0.0, "floatShares": 2042930, "sharesOutstanding": 2221860, "sharesShort": 17310, "sharesShortPriorMonth": 12336, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.0078, "heldPercentInsiders": 0.010319999, "heldPercentInstitutions": 0.02162, "shortRatio": 0.9, "shortPercentOfFloat": 0.0078, "impliedSharesOutstanding": 2221860, "bookValue": 4.989, "priceToBook": 0.37582684, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -12458000, "trailingEps": -9.24, "forwardEps": -2.73, "lastSplitFactor": "1:12", "lastSplitDate": 1674691200, "enterpriseToEbitda": 0.658, "52WeekChange": -0.79994243, "SandP52WeekChange": 0.2183963, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PHIO", "underlyingSymbol": "PHIO", "shortName": "Phio Pharmaceuticals Corp.", "longName": "Phio Pharmaceuticals Corp.", "firstTradeDateEpochUtc": 1336656600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "fedc8ae3-3efb-3824-9f0a-1fec231ff566", "messageBoardId": "finmb_140969529", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.875, "recommendationKey": "none", "totalCash": 11307000, "totalCashPerShare": 5.089, "ebitda": -12389000, "totalDebt": 104000, "quickRatio": 4.727, "currentRatio": 5.031, "debtToEquity": 1.05, "returnOnAssets": -0.47973, "returnOnEquity": -0.926, "grossProfits": -7012000, "freeCashflow": -6936250, "operatingCashflow": -11710000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "Else-KrOener-Strasse 1", "city": "Bad Homburg", "zip": "61352", "country": "Germany", "phone": "49 6172 609 0", "website": "https://www.freseniusmedicalcare.com", "industry": "Medical Care Facilities", "industryKey": "medical-care-facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.", "fullTimeEmployees": 124295, "companyOfficers": [{"maxAge": 1, "name": "Ms. Helen  Giza", "age": 54, "title": "CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 3214000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Franklin W. Maddux F.A.C.P.", "age": 65, "title": "Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 2416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William J. Valle", "age": 62, "title": "Management Board Member for Care Delivery of Fresenius Medical Care Management AG", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 3933000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Katarzyna  Mazur-Hofsab Ph.D.", "age": 59, "title": "Management Board Member for Care Enablement of Fresenius Medical Care Management AG", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 2345000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roberto  Fuste", "age": 70, "title": "Executive Advisor for Regional Strategy", "yearBorn": 1952, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Fischer", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dominik  Heger", "title": "Executive VP and Head of Investor Relations, Strategic Development & Communications", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Borries Von Muller", "age": 61, "title": "Senior Vice President of Global Human Resources Employee Communications", "yearBorn": 1961, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joachim  Weith", "title": "Senior Vice President of Corporate Communications & Governmental Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Oliver  Maier", "title": "Senior Vice President Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 1, "overallRisk": 8, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 20.95, "open": 17.72, "dayLow": 17.032, "dayHigh": 17.72, "regularMarketPreviousClose": 20.95, "regularMarketOpen": 17.72, "regularMarketDayLow": 17.032, "regularMarketDayHigh": 17.72, "dividendRate": 0.71, "dividendYield": 0.0301, "exDividendDate": 1652400000, "payoutRatio": 0.0, "fiveYearAvgDividendYield": 1.3, "beta": 0.915, "trailingPE": 15.925234, "forwardPE": 7.1297073, "volume": 1333677, "regularMarketVolume": 1333677, "averageVolume": 408359, "averageVolume10days": 374970, "averageDailyVolume10Day": 374970, "bid": 17.26, "ask": 17.27, "bidSize": 1400, "askSize": 900, "marketCap": 10011051008, "fiftyTwoWeekLow": 12.82, "fiftyTwoWeekHigh": 27.72, "priceToSalesTrailing12Months": 0.5101832, "fiftyDayAverage": 23.223, "twoHundredDayAverage": 21.90325, "trailingAnnualDividendRate": 1.12, "trailingAnnualDividendYield": 0.05346062, "currency": "USD", "enterpriseValue": 19253473280, "profitMargins": 0.030350002, "floatShares": 198902043, "sharesOutstanding": 586827008, "sharesShort": 1677344, "sharesShortPriorMonth": 867019, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.0029, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.08482, "shortRatio": 4.34, "impliedSharesOutstanding": 587502976, "bookValue": 46.106, "priceToBook": 0.36958316, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": -0.046, "netIncomeToCommon": 595625024, "trailingEps": 1.07, "forwardEps": 2.39, "pegRatio": 9.73, "lastSplitFactor": "2:1", "lastSplitDate": 1354579200, "enterpriseToRevenue": 0.981, "enterpriseToEbitda": 8.14, "52WeekChange": 0.63161993, "SandP52WeekChange": 0.2183963, "lastDividendValue": 0.618, "lastDividendDate": 1684281600, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "FMS", "underlyingSymbol": "FMS", "shortName": "Fresenius Medical Care AG", "longName": "Fresenius Medical Care AG & Co. KGaA", "firstTradeDateEpochUtc": 842967000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f13d3c2d-97b7-384c-acb0-6100954459d3", "messageBoardId": "finmb_384522", "gmtOffSetMilliseconds": -14400000, "currentPrice": 17.04, "targetHighPrice": 28.2, "targetLowPrice": 16.01, "targetMeanPrice": 22.11, "targetMedianPrice": 22.11, "recommendationMean": 4.0, "recommendationKey": "underperform", "numberOfAnalystOpinions": 2, "totalCash": 1361298048, "totalCashPerShare": 4.64, "ebitda": 2365314048, "totalDebt": 13065790464, "quickRatio": 0.756, "currentRatio": 1.26, "totalRevenue": 19622461440, "debtToEquity": 87.513, "revenuePerShare": 33.438, "returnOnAssets": 0.02596, "returnOnEquity": 0.05301, "grossProfits": 5310252000, "freeCashflow": 1400707072, "operatingCashflow": 2407247872, "earningsGrowth": -0.043, "revenueGrowth": 0.014, "grossMargins": 0.2669, "ebitdaMargins": 0.12054, "operatingMargins": 0.06646, "financialCurrency": "EUR", "trailingPegRatio": 1.4352}, {"address1": "600 W Chicago Avenue", "address2": "Suite 400", "city": "Chicago", "state": "IL", "zip": "60654", "country": "United States", "phone": "312 334 1579", "website": "https://www.groupon.com", "industry": "Internet Content & Information", "industryKey": "internet-content-information", "industryDisp": "Internet Content & Information", "sector": "Communication Services", "sectorKey": "communication-services", "sectorDisp": "Communication Services", "longBusinessSummary": "Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 2904, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dusan  Senkypl", "age": 46, "title": "Interim CEO & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": 18750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric P. Lefkofsky", "age": 52, "title": "Co-Founder & Independent Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 56250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dane Andrew Drobny", "age": 54, "title": "Outside Gen. Counsel", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 1599388, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jiri  Ponrt", "title": "Chief Financial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kyle  Netzly", "age": 40, "title": "Global Controller & Interim Chief Accounting Officer", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vojtech  Rysanek", "title": "Interim Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rana  Kashyap", "title": "Sr. VP of Corp. Devel. & Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emma  Coleman", "title": "Head of Global Communications", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Barbara  Weisz", "title": "Sr. VP of Sales", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kerrie  Dvorak", "age": 38, "title": "Chief Accounting Officer (Leave of Absence)", "yearBorn": 1984, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 9, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.875, "open": 9.82, "dayLow": 9.4, "dayHigh": 10.45, "regularMarketPreviousClose": 9.875, "regularMarketOpen": 9.82, "regularMarketDayLow": 9.4, "regularMarketDayHigh": 10.45, "payoutRatio": 0.0, "beta": 1.578292, "forwardPE": 13.532468, "volume": 711240, "regularMarketVolume": 711240, "averageVolume": 1453832, "averageVolume10days": 2169930, "averageDailyVolume10Day": 2169930, "bid": 9.97, "ask": 9.96, "bidSize": 900, "askSize": 4000, "marketCap": 325610400, "fiftyTwoWeekLow": 2.89, "fiftyTwoWeekHigh": 16.25, "priceToSalesTrailing12Months": 0.5993539, "fiftyDayAverage": 11.485, "twoHundredDayAverage": 7.299, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 484519104, "profitMargins": -0.28215, "floatShares": 17177678, "sharesOutstanding": 31248600, "sharesShort": 5365455, "sharesShortPriorMonth": 5445559, "sharesShortPreviousMonthDate": 1693440000, "dateShortInterest": 1695945600, "sharesPercentSharesOut": 0.1717, "heldPercentInsiders": 0.15775, "heldPercentInstitutions": 0.6107, "shortRatio": 4.64, "shortPercentOfFloat": 0.3863, "impliedSharesOutstanding": 31248600, "bookValue": -0.801, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -153284000, "trailingEps": -3.41, "forwardEps": 0.77, "pegRatio": -3.57, "lastSplitFactor": "1:20", "lastSplitDate": 1591833600, "enterpriseToRevenue": 0.892, "enterpriseToEbitda": -6.767, "52WeekChange": 0.34056985, "SandP52WeekChange": 0.2183963, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "GRPN", "underlyingSymbol": "GRPN", "shortName": "Groupon, Inc.", "longName": "Groupon, Inc.", "firstTradeDateEpochUtc": 1320413400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "04df0e24-e30c-3e43-9377-d56a70c1b96c", "messageBoardId": "finmb_82311805", "gmtOffSetMilliseconds": -14400000, "currentPrice": 10.42, "targetHighPrice": 15.0, "targetLowPrice": 4.0, "targetMeanPrice": 8.33, "targetMedianPrice": 6.0, "recommendationMean": 3.3, "recommendationKey": "hold", "numberOfAnalystOpinions": 3, "totalCash": 118145000, "totalCashPerShare": 3.781, "ebitda": -71597000, "totalDebt": 293892992, "quickRatio": 0.44, "currentRatio": 0.528, "totalRevenue": 543268992, "revenuePerShare": 17.761, "returnOnAssets": -0.06978, "returnOnEquity": -3.0927, "grossProfits": 522824000, "freeCashflow": -90740376, "operatingCashflow": -146260992, "revenueGrowth": -0.157, "grossMargins": 0.86977994, "ebitdaMargins": -0.13179, "operatingMargins": -0.15451999, "financialCurrency": "USD", "trailingPegRatio": null}, {"address1": "Novo Alle 1", "city": "Bagsvaerd", "zip": "2880", "country": "Denmark", "phone": "45 44 44 88 88", "website": "https://www.novonordisk.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.", "fullTimeEmployees": 59337, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lars Fruergaard Jorgensen", "age": 56, "title": "President, CEO & Member of Management Board", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 32300000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Karsten Munk Knudsen", "age": 51, "title": "Executive VP, CFO & Member of the Management Board", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 12800000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik Ehlers Wulff", "age": 52, "title": "Executive VP of Product Supply, Quality & IT and Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 12900000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Camilla  Sylvest", "age": 50, "title": "Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 12600000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martin Holst Lange", "age": 52, "title": "Executive VP of Development & Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 12200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marcus  Schindler Ph.D.", "age": 56, "title": "EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 12200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maziar Mike Doustdar", "age": 52, "title": "Executive VP of International Operations & Member of the Management Board", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Langa", "age": 56, "title": "Executive VP of North America Operations & Member of Management Board", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ludovic  Helfgott", "age": 48, "title": "Executive VP, Head of Rare Disease & Member of Management Board", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tania  Sabroe", "title": "Executive VP of Global People & Organisation and Member of Management Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 1, "shareHolderRightsRisk": 10, "overallRisk": 2, "governanceEpochDate": 1696118400, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 650.1, "open": 670.0, "dayLow": 667.5, "dayHigh": 680.0, "regularMarketPreviousClose": 650.1, "regularMarketOpen": 670.0, "regularMarketDayLow": 667.5, "regularMarketDayHigh": 680.0, "dividendRate": 7.08, "dividendYield": 0.0109, "exDividendDate": 1692316800, "payoutRatio": 0.4165, "fiveYearAvgDividendYield": 1.78, "beta": 0.21, "trailingPE": 45.533913, "forwardPE": 32.02645, "volume": 2291250, "regularMarketVolume": 2291250, "averageVolume": 2879297, "averageVolume10days": 2462476, "averageDailyVolume10Day": 2462476, "bid": 677.9, "ask": 678.3, "bidSize": 0, "askSize": 0, "marketCap": 3031507402752, "fiftyTwoWeekLow": 384.0, "fiftyTwoWeekHigh": 690.3, "priceToSalesTrailing12Months": 15.057779, "fiftyDayAverage": 638.124, "twoHundredDayAverage": 554.57275, "trailingAnnualDividendRate": 7.075, "trailingAnnualDividendYield": 0.010882941, "currency": "DKK", "enterpriseValue": 2908504981504, "profitMargins": 0.33398, "floatShares": 3215036592, "sharesOutstanding": 3358370048, "impliedSharesOutstanding": 4433249792, "bookValue": 20.185, "priceToBook": 33.5893, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "earningsQuarterlyGrowth": 0.459, "netIncomeToCommon": 67238998016, "trailingEps": 14.89, "forwardEps": 21.17, "pegRatio": 1.29, "lastSplitFactor": "2:1", "lastSplitDate": 1694563200, "enterpriseToRevenue": 14.447, "enterpriseToEbitda": 31.31, "52WeekChange": 0.6232209, "SandP52WeekChange": 0.2183963, "lastDividendValue": 3.0, "lastDividendDate": 1692316800, "exchange": "CPH", "quoteType": "EQUITY", "symbol": "NOVO-B.CO", "underlyingSymbol": "NOVO-B.CO", "shortName": "Novo Nordisk B A/S", "longName": "Novo Nordisk A/S", "firstTradeDateEpochUtc": 978768000, "timeZoneFullName": "Europe/Copenhagen", "timeZoneShortName": "CEST", "uuid": "dc21647a-ac72-3024-917d-9a82cdc63d38", "messageBoardId": "finmb_323452", "gmtOffSetMilliseconds": 7200000, "currentPrice": 678.0, "targetHighPrice": 810.0, "targetLowPrice": 360.0, "targetMeanPrice": 646.26, "targetMedianPrice": 665.0, "recommendationMean": 2.6, "recommendationKey": "hold", "numberOfAnalystOpinions": 25, "totalCash": 36408000512, "totalCashPerShare": 8.108, "ebitda": 92893003776, "totalDebt": 25703999488, "quickRatio": 0.683, "currentRatio": 0.878, "totalRevenue": 201325002752, "debtToEquity": 28.411, "revenuePerShare": 44.689, "returnOnAssets": 0.21757999, "returnOnEquity": 0.81539, "grossProfits": 148506000000, "freeCashflow": 53321375744, "operatingCashflow": 89730998272, "earningsGrowth": 0.473, "revenueGrowth": 0.316, "grossMargins": 0.84353995, "ebitdaMargins": 0.46141, "operatingMargins": 0.43993, "financialCurrency": "DKK", "trailingPegRatio": 5.3544}, {"address1": "Times Square Tower", "address2": "Suite 2503 7 Times Square", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. The company is headquartered in New York, New York.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 46, "title": "Founder, Pres, CEO & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": 921985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Barbara A. Wood Esq.", "age": 59, "title": "Exec. VP, Gen. Counsel & Corp. Sec.", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 632660, "exercisedValue": 0, "unexercisedValue": 8078}, {"maxAge": 1, "name": "Mr. Robert M. Francomano", "age": 55, "title": "Sr. VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 667354, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 37, "title": "Sr. VP & CFO", "yearBorn": 1985, "fiscalYear": 2019, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 59, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1963, "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "VP and Head of Regulatory Affairs, Chemistry, Manufacturing and Controls & Quality", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.42, "open": 1.41, "dayLow": 1.1801, "dayHigh": 1.52, "regularMarketPreviousClose": 1.42, "regularMarketOpen": 1.41, "regularMarketDayLow": 1.1801, "regularMarketDayHigh": 1.52, "payoutRatio": 0.0, "beta": 2.311441, "forwardPE": -1.2554255, "volume": 3962811, "regularMarketVolume": 3962811, "averageVolume": 146729, "averageVolume10days": 241270, "averageDailyVolume10Day": 241270, "bid": 1.32, "ask": 1.33, "bidSize": 1400, "askSize": 900, "marketCap": 33453356, "fiftyTwoWeekLow": 1.17, "fiftyTwoWeekHigh": 5.58, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 1.5236, "twoHundredDayAverage": 1.8801, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 27479526, "profitMargins": 0.0, "floatShares": 28271664, "sharesOutstanding": 28347900, "sharesShort": 1019308, "sharesShortPriorMonth": 1134870, "sharesShortPreviousMonthDate": 1692057600, "dateShortInterest": 1694736000, "sharesPercentSharesOut": 0.036, "heldPercentInsiders": 0.002, "heldPercentInstitutions": 0.18039, "shortRatio": 8.81, "shortPercentOfFloat": 0.036, "impliedSharesOutstanding": 28347900, "bookValue": 0.171, "priceToBook": 6.9011693, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1688083200, "netIncomeToCommon": -36080000, "trailingEps": -1.45, "forwardEps": -0.94, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": -0.23655915, "SandP52WeekChange": 0.2183963, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SLS", "underlyingSymbol": "SLS", "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "firstTradeDateEpochUtc": 1205328600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d5f0c150-9f89-3f17-8497-1832af4e7670", "messageBoardId": "finmb_262231850", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.1801, "recommendationMean": 1.7, "recommendationKey": "buy", "totalCash": 13807000, "totalCashPerShare": 0.487, "totalDebt": 749000, "quickRatio": 1.029, "currentRatio": 1.161, "totalRevenue": 0, "debtToEquity": 15.466, "revenuePerShare": 0.0, "returnOnAssets": -0.90897006, "returnOnEquity": -3.01925, "grossProfits": 900000, "freeCashflow": -22516876, "operatingCashflow": -30591000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null}]}